COOT 10-Q Quarterly Report March 31, 2025

AUSTRALIAN OILSEEDS HOLDINGS LTD

10-Ks,20-Fs and 10-Qs

20-F	Fiscal year ended June 30, 2025
10-Q	Quarter ended March 31, 2025
10-Q	Quarter ended Dec. 31, 2024
10-Q	Quarter ended Sept. 30, 2024
10-K	Fiscal year ended June 30, 2024
20-F	Fiscal year ended March 21, 2024

PROXIES

DEF 14A	Filed on July 14, 2025
DEF 14A	Filed on March 21, 2025

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: March 31, 2025

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-41986

AUSTRALIAN OILSEEDS HOLDINGS LTD.

(Exact name of registrant as specified in its charter)

Cayman Islands

N/A

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

126 – 142 Cowcumbla Street, Cootamundra

Site 2: 52 Fuller Drive Cootamundra

PO Box 263 Cootamundra , Australia 2590

N/A

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: +02 6942 4347

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
Ordinary Shares, par value $.0001 per share	COOT	The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share	COOTW	The Nasdaq Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☐ No ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

	Large accelerated filer ☐		Accelerated filer ☐
	Non-accelerated filer ☒		Smaller reporting company ☒
			Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for comply with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of May 29, 2025, there were 27,898,538 ordinary shares of the registrant issued and outstanding.

AUSTRALIAN OILSEEDS HOLDINGS LTD.

Quarterly Report on Form 10-Q

Period Ended March 31, 2025

TABLE OF CONTENTS

		Page
PART I FINANCIAL INFORMATION
Item 1.	Financial Statements
	Unaudited Condensed Consolidated Statements of Financial Position	1
	Unaudited Condensed Consolidated Statements of Profit or (loss) and other Comprehensive Income (Loss)	2
	Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity	3
	Unaudited Condensed Consolidated Statements of Cash Flows	4
	Notes to Unaudited Condensed Consolidated Financial Statements	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	34
Item 4.	Controls and Procedures	34
PART II OTHER INFORMATION
Item 1.	Legal Proceedings	35
Item 1A.	Risk Factors	35
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	35
Item 3.	Defaults Upon Senior Securities	35
Item 4.	Mine Safety Disclosures	35
Item 5.	Other Information	35
Item 6.	Exhibits	35

AUSTRALIAN OILSEEDS HOLDINGS LTD.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
AS AT 31 MARCH 2025 AND 30 JUNE 2024

	Note	31 March 2025			30 June 2024
		AUD$			AUD$
ASSETS
CURRENT ASSETS
Cash and cash equivalents			1,435,123			514,140
Trade and other receivables	3		5,743,369			4,470,101
Inventories	4		4,180,903			6,202,160
Other current assets	6		602,686			201,830
TOTAL CURRENT ASSETS			11,962,081			11,388,231
NON-CURRENT ASSETS
Property, plant and equipment	5		15,661,741			14,617,513
Right-of-use asset	11		872,378			944,420
Other assets	6		-			429,841
Deferred tax assets			34,270			34,270
Intangible assets			2,582,495			2,582,495
TOTAL NON-CURRENT ASSETS			19,150,884			18,608,539
TOTAL ASSETS			31,112,965			29,996,770
LIABILITIES
CURRENT LIABILITIES
Trade and other payables	7		9,025,055			10,455,684
Borrowings	8		978,574			978,574
Lease liability, current	11		89,109			89,109
Income Tax liabilities			-			128,927
Related party loans	21		8,404,186			4,111,661
Convertible note, net of discount	8		1,651,041			1,181,953
Warrant liabilities	10,22		247,732			238,613
Promissory note – related party, current	21		1,040,641			968,216
Employee benefits			148,054			201,024
TOTAL CURRENT LIABILITIES			21,584,392			18,353,761
NON-CURRENT LIABILITIES
Borrowings	8		4,473,489			5,051,910
Promissory note - related party, non-current	21		273,676			273,676
Lease liability, non-current	11		812,513			879,347
Related party loans	21		4,981,586			4,530,507
TOTAL NON-CURRENT LIABILITIES			10,541,264			10,735,440
TOTAL LIABILITIES			32,125,656			29,089,201
NET (LIABILITIES)/ASSET			( 1,012,691	)		907,569
EQUITY
Share capital			3,562			3,562
Share premium			17,064,658			17,064,658
Foreign currency translation reserve			( 322,960	)		-
Accumulated losses			( 19,451,943	)		( 17,950,222	)
Total deficit attributable to equity holders of the Company			( 2,706,683	)		( 882,002	)
Non-controlling interest			1,693,992			1,789,571
TOTAL (DEFICIT)/EQUITY			( 1,012,691	)		907,569

The accompanying notes are an integral part of these condensed consolidated financial statements.

AUSTRALIAN OILSEEDS HOLDINGS LTD.

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR (LOSS) AND OTHER COMPREHENSIVE INCOME (LOSS)

FOR THE THREE MONTHS AND NINE MONTHS ENDED 31 MARCH 2025 AND 31 MARCH 2024

	Note	THREE MONTHS ENDED MAR 2025			THREE MONTHS ENDED MAR 2024			NINE MONTHS ENDED MAR 2025			NINE MONTHS ENDED MAR 2024
		AUD$			AUD$			AUD$			AUD$
Sales revenue	12		9,430,228			6,295,851			30,163,944			25,986,786
Cost of sales	13		( 8,864,653	)		( 5,692,410	)		( 27,562,995	)		( 21,068,310	)
Gross profit			565,575			603,441			2,600,949			4,918,476
General and administrative expenses	14		( 628,578	)		( 421,954	)		( 2,600,422	)		( 1,921,093	)
Selling and marketing expenses	15		( 70,022	)		( 15,000	)		( 354,556	)		( 270,205	)
Other income	16		22,724			36,958			86,253			79,785
Operating (loss)/profit			( 110,301	)		203,445			( 267,776	)		2,806,963
Finance expenses	18		( 471,238	)		( 162,260	)		( 1,280,428	)		( 384,859	)
(Loss) Profit before income tax			( 581,539	)		41,185			( 1,548,204	)		2,422,104
Income tax expense			( 49,094	)		-			( 49,094	)		-
(Loss) Profit for the period			( 630,633	)		41,185			( 1,597,298	)		2,422,104
Other comprehensive income for the period, net of tax			-			-			-			-
Total comprehensive (loss) income			( 630,633	)		41,185			( 1,597,298	)		2,422,104
(Loss) Profit attributable to:
Members of the parent entity			( 559,758	)		26,324			( 1,501,719	)		1,858,356
Non-controlling interest			( 70,875	)		14,861			( 95,579	)		563,748
Total (Loss) Income			( 630,633	)		41,185			( 1,597,298	)		2,422,104
Total comprehensive (loss) income attributable to:
Members of the parent entity			( 559,758	)		26,324			( 1,501,719	)		1,858,356
Non-controlling interest			( 70,875	)		14,861			( 95,579	)		563,748
Total			( 630,633	)		41,185			( 1,597,298	)		2,422,104
(Loss) Earnings per share attributable to the ordinary equity holders of the parent
Profit or loss
Basic (loss) earnings per share (cents)	19		( 0.03	)		0.00			( 0.07	)		0.13
Diluted (loss) earnings per share (cents)	19		( 0.03	)		0.00			( 0.07	)		0.13

The accompanying notes are an integral part of these condensed consolidated financial statements.

AUSTRALIAN OILSEEDS HOLDINGS LTD.

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY
FOR THE THREE AND NINE MONTHS ENDED 31 MARCH 2025 AND 31 MARCH 2024

	Shares		Share		Accumulated			Non-controlling			Foreign currency translation
	Capital		Premium		Losses			Interests			reserve			Total
	AUD$		AUD$		AUD$			AUD$			AUD$			AUD$
Balance on 30 June 2024		3,562		17,064,658		( 17,950,222	)		1,789,571			-			907,569
Loss for the period attributable to members of the parent entity		-		-		( 613,664	)		( 32,671	)		-			( 646,335	)
Balance on 30 September 2024		3,562		17,064,658		( 18,563,886	)		1,756,900			-			261,234
Loss for the period attributable to members of the parent entity		-		-		( 328,299	)		7,967			-			( 320,332	)
Balance on 31 December 2024		3,562		17,064,658		( 18,892,185	)		1,764,867			-			( 59,098	)
(Loss) profit for the period attributable to members of the parent entity		-		-		( 559,758	)		( 70,875	)		-			( 630,633	)
Unrealised loss on translation												( 322,960	)		( 322,960	)
Balance on 31 March 2025		3,562		17,064,658		( 19,451,943	)		1,693,992			( 322,960	)		( 1,012,691	)

	Shares		Share		Retained		Non-controlling			Foreign currency translation
	Capital		Premium		Earnings		Interests			reserve		Total
	AUD$		AUD$		AUD$		AUD$			AUD$		AUD$
Balance on 30 June 2023, restated		2,860		2,579,627		3,712,333		1,357,697			-		7,652,517
Profit for the period attributable to members of the parent entity		-		-		1,096,364		314,167			-		1,410,531
Balance on 30 September 2023		2,860		2,579,627		4,808,697		1,671,864			-		9,063,048
Profit for the period attributable to members of the parent entity		-		-		735,668		234,720			-		970,388
Balance on 30 December 2023		2,860		2,579,627		5,544,365		1,906,584			-		10,033,436
Balance		2,860		2,579,627		5,544,365		1,906,584			-		10,033,436
Profit for the period attributable to members of the parent entity		-		-		26,324		14,861			-		41,185
(Loss) profit for the period attributable to members of the parent entity		-		-		26,324		14,861			-		41,185
Dividend paid to shareholders								( 37,931	)		-		( 37,931	)
Balance on 31 March 2024		2,860		2,579,627		5,570,689		1,883,514			-		10,036,690
Balance		2,860		2,579,627		5,570,689		1,883,514			-		10,036,690

The accompanying notes are an integral part of these consolidated financial statements.

AUSTRALIAN OILSEEDS HOLDINGS LTD.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE NINE MONTHS ENDED 31 MARCH 2025 AND 31 MARCH 2024

	Note	2025			2024
		AUD$			AUD$

CASH FLOWS FROM OPERATING ACTIVITIES:
Receipts from customers			28,976,930			29,099,972
Payments to suppliers and employees			( 29,894,989	)		( 27,011,986	)
Tax Refund received/Income tax paid			( 209,786	)		( 440,473	)
Interest paid			( 815,124	)		( 388,028	)
Net cash (used in)/provided by operating activities	20		( 1,942,969	)		1,259,485
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property, plant and equipment			( 901,918	)		( 3,302,050	)
Net cash (used in) investing activities			( 901,918	)		( 3,302,050	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from related parties’ loans			4,556,838			4,732,555
Proceeds from secured borrowings			1,971,103			3,978,651
Repayment of related parties’ loans			-			( 3,787,538	)
Repayment of secured borrowings			( 2,712,831	)		( 1,992,041	)
Repayment of lease liability			( 49,240	)		( 34,207	)
Dividends paid			-			( 37,931	)
Net cash provided by financing activities			3,765,870			2,859,489
Net increase in cash and cash equivalents held			920,983			816,926
Cash and cash equivalents at beginning of period			514,140			121,273
Cash and cash equivalents at the end of March period			1,435,123			938,198

AUSTRALIAN OILSEEDS HOLDINGS LTD.

Notes to Unaudited Condensed Consolidated Financial Statements

1. Establishment and Operations

Australian Oilseeds Holdings Limited (“ Australian Oilseeds ” or the “ Company ”) is a Cayman Islands exempted company that, directly and indirectly through its subsidiaries, is focused on the manufacture and sale of chemical free, non-GMO, sustainable edible oils and products derived from oilseeds. The Company believes that transitioning from a fossil fuel economy to a renewable and chemical free economy is the solution to many health problems the world is facing presently. To that end, the Company is committed to working with suppliers and customers to eliminate chemicals from the edible oil production and manufacturing systems to supply quality products such as non-GMO oilseeds and organic and non-organic food-grade oils to customers globally. Over the past 20 years, Australian Oilseeds Investments Pty Ltd., an Australian proprietary company (“AOI”) has grown to be the largest cold pressing oil plant in Australia, pressing strictly GMO free conventional and organic oilseeds.

The main business activities include the mill of GMO free conventional and organic oilseeds to produce vegetable oils and related products to wholesale and retail market.

The material accounting policies adopted in the preparation of the consolidated financial statements are set out in Note 2. The policies have been consistently applied to all the years presented, unless otherwise stated.

The condensed consolidated financial statements are presented in AUD, which is also the Company’s functional currency.

Amounts are rounded to the nearest dollar, unless otherwise stated.

These financial statements have been prepared in accordance with IFRS Accounting Standards as issued by the International Accounting Standards Board (IASB) (collectively IFRS Accounting Standards).

The preparation of financial statements in compliance with adoption of IFRS Accounting Standards requires the use of certain critical accounting estimates. It also requires Company management to exercise judgment in applying the Company’s accounting policies. The areas where significant judgments and estimates have been made in preparing the financial statements and their effects are disclosed in note 2.

Reverse Recapitalization

Australian Oilseeds Holdings Ltd (“PubCo”) was incorporated in Cayman Islands business company with limited liability and was formed for the purpose of participating in the transactions contemplated hereby and becoming the publicly traded holding company for the surviving corporation.

EDOC Acquisition Corp (“EDOC” or “SPAC”) is a Cayman Islands exempted company formerly listed on the NASDAQ Stock Market under “ADOC”. EDOC has limited operations but is established as a public investment vehicle that has the express purpose of making an investment in an operating company.

On March 21, 2024 (the “Closing Date”), the Company consummated the previously announced Business Combination (defined below). The Business Combination was announced on December 7, 2022, where AOI, PubCo, and EDOC entered into a business combination agreement (“Business Combination Agreement”), pursuant to which, (a) EDOC merged with and into Merger Sub, with EDOC continuing as the surviving entity (the “Merger”), and with holders of EDOC securities receiving substantially identical securities of Pubco, and (b) immediately prior to the Merger, Pubco acquired all of the issued and outstanding ordinary shares of AOI (the “Purchased Shares”) from the Sellers in exchange for ordinary shares of Pubco, with AOI became a wholly-owned subsidiary of Pubco (the “Share Exchange”, and together with the Merger and the other transactions contemplated by the Business Combination Agreement, the “Transactions”).

The total consideration paid by Pubco to the sellers for the purchased shares was an aggregate number of Pubco ordinary shares (the “Exchange Shares”) with an aggregate value (the “Exchange Consideration”) equal to, without duplication, (i) USD$ 190,000,000 , plus (or minus, if negative) (ii) AOI’s net working capital less a target net working capital of USD$ 4,000,000 , minus (iii) the aggregate amount of any outstanding indebtedness, net of cash and cash equivalents, of AOI and its subsidiaries, and minus (iv) the amount of any unpaid transaction expenses of AOI, with each Pubco ordinary share issued to the sellers valued at USD$ 10.00 .

The Merger was consummated on March 21, 2024, and the Share Exchange and Business Combination were consummated on the Closing Date. Pursuant to the Business Combination Agreement, upon the consummation of the Business Combination at the effective time of the Business Combination (the “Effective Time”):

	●	each holder of EDOC pre-transaction privately-held Class A ordinary shares and the Class B ordinary share (the “EDOC Ordinary Shares”) received a number of Company Ordinary Shares, which are listed under the ticker “COOT” (less 200,000 Class A ordinary shares that were forfeited to the Company;

	●	each holder of AOI ordinary shares received Company Ordinary Shares on a one-for-one basis (the “Exchange Shares”);

	●	each holder of EDOC’s public Class A ordinary shares received Company Ordinary Shares on a one-for-one basis;

	●	EDOC’s warrants terminated and were exchanged for warrants of the Company (the “Warrants”), which Warrants are listed on the Nasdaq under “COOTW”;

	●	each holder of EDOC’s rights (the “Rights”) received 1/10 of a Company Ordinary Share for each such Right, as set forth herein;

	●	EDOC’s Rights will no longer be traded;

	●	EDOC’s 479,000 placement units (“Placement Units”) were exchanged for Company Ordinary Shares and Warrants of the Company; and

	●	EDOC’s USD$ 1,500,000 of convertible promissory notes that were convertible at Closing into Company Ordinary Shares (“Convertible Shares”) and warrants (“Convertible Warrants”).

On March 22, 2024, the Ordinary Shares and PubCo Warrants commenced trading on the Nasdaq Capital Market (“Nasdaq”) under the symbols “COOT” and “COOTW,” respectively.

2. Summary of Material Accounting Policies

(a) Unaudited Interim Financial Information

The accompanying condensed consolidated statement of financial position as of 31 March 2025, and the condensed consolidated statements of profit or loss and other comprehensive income (loss), changes in equity and cash flows for the three and nine months ended 31 March 2025 and 2024 are unaudited and have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in annual financial statements prepared in accordance with IFRS Accounting Standards have been omitted pursuant to those rules or regulations. The unaudited interim condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the Company’s financial position as of 31 March 2025 and the results of operations and cash flows for the nine months ended 31 March 2025 and 2024. The results of operations for the three and nine months ended 31 March 2025 are not necessarily indicative of the results to be expected for the year ending 30 June 2025 or for any other interim period or other future year. The following information should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K/A for the fiscal year ended 30 June 2024.

(b) Basis of consolidation

Australian Oilseeds Holdings Ltd. is a Cayman Islands exempted company (the “Company,” “we,” “us” or “Australian Oilseeds”) formed on December 29, 2022. The Company’s subsidiaries include Australian Oilseeds Investments Pty Ltd., an Australian proprietary company; Good Earth Oils Pty Ltd. an Australian proprietary company; Cowcumbla Investments Pty Ltd., an Australian proprietary company, which is 82.7 % owned by the Company and which wholly owns Cootamundra Oilseeds Pty Ltd., which is incorporated in Australia; and EDOC Acquisition Corp., a Cayman Islands exempted company.

The Company’s financial statements comprise the financial statements of the Company and its subsidiaries as of June 30, each year. Subsidiaries are consolidated from the date of their acquisition, being the date on which the Company obtains control, and continue to be consolidated until the date that control ceases. The financial statements of subsidiaries are prepared for the same reporting year as the parent Company, using consistent accounting policies. Intra-company balances and transactions, including unrealized profits arising from intra-company transactions, have been eliminated. Unrealized losses are eliminated unless the transaction provides evidence of an impairment of the asset transferred. Non-controlling interests represent the equity in subsidiaries that is not attributable, directly or indirectly, to the Parent shareholders.

Details of subsidiaries as of 31 March 2025 and 30 June 2024 were as follows:

Schedule of Subsidiaries

Subsidiaries	% of legal ownership 31 Mar 2025			% of legal ownership 30 Jun 2024			Country of Incorporation	Principal business activities
Australian Oilseeds Pty Ltd.		100	%		100	%	Australia	Investment

Cootamundra Oilseeds Pty Ltd.		82.7	%		82.7	%	Australia	Oilseeds crushing business

Cowcumbla Investments Pty Ltd.		82.7	%		82.7	%	Australia	Investment

Good Earth Oils Pty Ltd.		100	%		100	%	Australia	Marketing and Distribution

EDOC Acquisition Limited		100	%		100	%	Cayman Islands	SPAC

The carrying amount of the Company’s investment in the subsidiary and the equity of the subsidiary is eliminated on consolidation.

(c) Substantial doubt regarding Going Concern

The Company incurred a loss after income tax for three months ended 31 March 2025 of AUD$ 630,633 (31 March 2024: Profit AUD$ 41,185 ) and for nine months ended 31 March 2025 a loss of AUD$ 1,597,298 (31 March 2024: Profit AUD$ 2,422,104 ). The Company was in a net current liability position of AUD$ 9,622,311 as of 31 March 2025 (30 June 2024: AUD$ 6,965,530 ). Net cash outflow from operating activities was AUD$ 1,942,969 for the nine months ended 31 March 2025 (31 March 2024: Inflow AUD$ 1,259,485 ).

As of 31 March 2025, the consolidated entity had cash in hand and at bank of AUD$ 1,435,123 (30 June 2024: AUD$ 514,140 ).

The above factors raise substantial doubt about the Company’s ability to continue as a going concern unless it can successfully meet the stated objectives and/or raise additional funds with its financiers and investors.

As at 31 March 2025, all banking covenants associated with the borrowings from the Commonwealth Bank of Australia were in compliance. There are two covenants being:

	●	The interest cover ratio in respect of the obligor must for each reporting period be no less than 2.50 times; and
	●	The net working capital ratio must at all times be more than 80%.

The Company’s ability to continue its business activities as a going concern is dependent upon the Company deriving sufficient cash from the business operation and being able to draw down additional long-term debt from the senior debt provider, CBA, who has provided a total facility loan of AUD$ 14,000,000 with unused facilities as at 31 March 2025 of AUD$ 8,000,000 which is repayable on demand. In addition, the Company also has the ability to draw down an additional US$ 6 million of redeemable debentures from the existing PIPE investors or executing a US$ 50 million equity line of credit (ELOC) once the Company lodges the registration statement of the ELOC.

Accordingly, the directors have prepared the financial statements on a going concern basis which contemplates continuity of normal activities and realization of assets and settlement of liabilities in the normal course of business.

Should the Company be unable to obtain funding from banks or other financiers, PIPE investors or fail to execute the ELOC, the Company may be required to realize its assets and discharge its liabilities other than in normal course of business and at amounts different to those stated in these financial statements. The financial statements do not include any adjustments to the recoverability and classification of asset carrying amounts or amounts of liabilities that might result should the Company be unable to continue as a going concern.

(d) Financial instruments

Financial instruments are recognised initially on the date that the Company becomes party to the contractual provisions of the instrument.

On initial recognition, all financial instruments are measured at fair value plus transaction costs (except for instruments measured at fair value through profit or loss where transaction costs are expensed as incurred).

Concentration of Key Customers

A substantial portion of the Company’s products are sold to its top five customers. For the three months ending 31 March 2025 and 2024, 87.9 % and 96.9 %, respectively, of total sales by the Company were to its top five customers.

	Unaudited Total Sales for The Three Months Ended		Unaudited Total Sales for The Nine Months Ended		Unaudited Outstanding Balance of Trade Receivables as at
	31 March 2025		31 March 2025		31 March 2025
Customer	AUD$		AUD$		AUD$
Energreen Nutrition Australia Pty Ltd.		3,271,722		6,389,585		799,737
Costco Wholesale Australia.		2,804,736		9,447,600		1,095,600
Daabon Organic Australia & Daabon Japan Pty Ltd.		845,799		2,801,858		1,426,824
Woolworths		845,602		2,579,650		293,836
DA Hall T/A Ellerslie Free Range Farms		523,598		758,721		162,992

	Unaudited Total Sales for the Three Months Ended 31 March 2024		Unaudited Total Sales for the Nine Months Ended 31 March 2024		Unaudited Outstanding Balance of Trade Receivables as at 31 March 2024
Customer	AUD$		AUD$		AUD$
Energreen Nutrition Australia Pty Ltd.		2,394,423		5,566,131		23,820
Daabon Organic Australia & Daabon Japan Pty Ltd.		1,963,337		4,374,724		1,463,988
Costco Wholesale Australia		422,400		4,399,629		422,400
Woolworths		754,963		754,963		461,602
Hygain NSW (Proprietary) Limited		567,528		2,887,691		101,193
Total Sales		567,528		2,887,691		101,193

If the sales performance of any of the Company’s key customers declines or if they terminate their cooperation with us or start to cooperate with any of the Company’s competitors, or if there is any modification as to the sales and purchase terms entered into with any of our key customers, our business, financial condition and revenue would be seriously impacted.

Impairment of financial assets

Impairment of financial assets is recognised on an expected credit loss (ECL) basis for the following assets:

	●	financial assets measured at amortised cost; and

	●	debt investments measured at FVOCI.

When determining whether the credit risk of a financial asset has increased significantly since initial recognition and when estimating ECL, the Company considers reasonable and supportable information that is relevant and available without undue cost or effort. This includes both quantitative and qualitative information and analysis based on the Company’s historical experience and informed credit assessment and including forward-looking information.

The Company uses the presumption that an asset which is more than 30 days past due has seen a significant increase in credit risk.

The Company uses the presumption that a financial asset is in default when:

	●	the other party is unlikely to pay its credit obligations to the Company in full, without recourse to the Company to actions such as realising security (if any is held); or

	●	the financial assets is more than 90 days past due.

Credit losses are measured as the present value of the difference between the cash flows due to the Company in accordance with the contract and the cash flows expected to be received. This is applied using a probability weighted approach.

Trade receivables and contract assets

Impairment of trade receivables and contract assets have been determined using the simplified approach in IFRS 9 which uses an estimation of lifetime expected credit losses. The Company has determined the probability of non-payment of the receivable and contract assets and multiplied this by the amount of the expected loss arising from default.

The amount of the impairment is recorded in a separate allowance account with the loss being recognised in finance expense. Once the receivable is determined to be uncollectable then the gross carrying amount is written off against the associated allowance.

Where the Company renegotiates the terms of trade receivables due from certain customers, the new expected cash flows are discounted at the original effective interest rate and any resulting difference to the carrying value is recognised in profit or loss.

Other financial assets measured at amortised cost

Impairment of other financial assets measured at amortised cost are determined using the expected credit loss model in IFRS 9. On initial recognition of the asset, an estimate of the expected credit losses for the next 12 months is recognised. Where the asset has experienced significant increase in credit risk then the lifetime losses are estimated and recognised.

Financial liabilities

The Company measures all financial liabilities initially at fair value less transaction costs, subsequently financial liabilities are measured at amortised cost using the effective interest rate method.

The financial liabilities of the Company comprise trade payables, bank and other loans, lease liabilities, and financial instruments.

Financial instruments were reviewed at Quarter end and there were no material changes in their fair values noted between balance dates.

(e) Impairment of non-financial assets

At the end of each reporting period the Company determines whether there is evidence of an impairment indicator for non-financial assets.

Where an indicator exists and regardless of goodwill, indefinite life intangible assets and intangible assets not yet available for use, the recoverable amount of the asset is estimated.

Where assets do not operate independently of other assets, the recoverable amount of the relevant cash-generating unit (CGU) is estimated.

The recoverable amount of an asset or CGU is the higher of the fair value, less costs of disposal and the value in use. Value in use is the present value of the future cash flows expected to be derived from an asset or cash-generating unit.

Where the recoverable amount is less than the carrying amount, an impairment loss is recognised in profit or loss.

Reversal indicators are considered in subsequent periods for all assets which have suffered an impairment loss, except for goodwill.

(f) Intangible assets

Goodwill

Goodwill is carried at cost less accumulated impairment losses.

The value of goodwill recognised on the acquisition of each subsidiary in which the Company holds less than 100 % interest will depend on the method adopted in measuring the aforementioned non-controlling interest. The Company can elect to measure the non-controlling interest in the acquiree either at fair value (full goodwill method’) or at the non-controlling interest’s proportionate share of the subsidiary’s identifiable net assets (proportionate interest method’). The Company determines which method to adopt for each acquisition.

Under the ‘full goodwill method’, the fair values of the non-controlling interests are determined using valuation techniques which make the maximum use of market information where available.

Goodwill on acquisitions of subsidiaries is included in intangible assets. Goodwill on acquisition of associates is included in investments in associates. Goodwill is not amortised but is tested for impairment annually at the end of financial year and is allocated to the Company’s cash generating units or groups of cash generating units, which represent the lowest level at which goodwill is monitored but where such a level is not larger than an operating segment. Gains and losses on the disposal of an entity include the carrying amount of goodwill related to the entity sold.

(g) Cash and cash equivalents

Cash and cash equivalents comprise cash on hand, demand deposits and short-term investments which are readily convertible to known amounts of cash and which are subject to an insignificant risk of change in value.

(h) Employee benefits

Provision is made for the Company’s liability for employee benefits arising from services rendered by employees to the end of the reporting period. Employee benefits that are expected to be wholly settled within one year have been measured at the amounts expected to be paid when the liability is settled. Employee benefits expected to be settled more than one year after the end of the reporting period have been measured at the present value of the estimated future cash outflows to be made for those benefits. In determining the liability, consideration is given to employee wage increases and the probability that the employee may satisfy vesting requirements. Cashflows are discounted using market yields on high quality corporate bond rates incorporating bonds rated AAA or AA by credit agencies, with terms to maturity that match the expected timing of cashflows. Changes in the measurement of the liability are recognised in profit or loss.

(i) Provisions

Provisions are recognised when the Company has a legal or constructive obligation, as a result of past events, for which it is probable that an outflow of economic benefits will result, and that outflow can be reliably measured.

Provisions are measured at the present value of management’s best estimate of the outflow required to settle the obligation at the end of the reporting period. The discount rate used is a pre-tax rate that reflects current market assessments of the time value of money and the risks specific to the liability. The increase in the provision due to the unwinding of the discount is taken to finance costs in the consolidated statement of profit or loss and other comprehensive income.

(j) Convertible Promissory Note

Convertible notes are presented as a financial liability in the consolidated statement of financial position. On issuance of the convertible notes, the liability is measured at fair value, and subsequently carried at amortised cost (net of transaction costs) until it is extinguished on conversion or redemption. Convertible notes are classified as current liabilities based on the expected conversion date in accordance with the convertible note’s agreements.

(k) Derivative warrant liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to IAS 32 and IFRS 9. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

The Company accounts for its 479,000 Private Warrants and 450,000 Representative’s Warrants issued in connection with its Initial Public Offering as derivative warrant liabilities in accordance with IAS 32 and IFRS 9. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of profit or loss. The fair value of warrants issued by the Company in connection with the Public Offering and Private Placement has been estimated using Monte-Carlo simulations at each measurement date.

The Company accounts for its 458,720 Warrants issued in connection with the issuance of the convertible debenture as derivative warrant liabilities in accordance with IAS 32 IFRS 9. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of profit or loss.

(l) Embedded Derivatives

A derivative embedded in a hybrid contract is separated from the host and accounted for as a separate derivative if, the economic characteristics and risks are not closely related to the host, a separate instrument with the same terms as the embedded derivative would meet the definition of a derivative, and the hybrid contract is not measured at fair value through profit or loss. Embedded derivatives are measured at fair value with changes in fair value recognised in profit or loss. Reassessment only occurs if there is either a change in the terms of the contract that significantly modifies the cash flows that would otherwise be required or a reclassification of a financial asset out of the fair value through profit or loss category.

(m) Segment Reporting

Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. As such, the Company has determined that it operates as one operating segment.

(n) New and amended standards and interpretations

i) New standards, amendments to published approved accounting and reporting standards and interpretations which are effective during the year

The Company has applied the following standards and amendments for the first time for its annual reporting for the period commencing 1 July 2024:

●	Definition of Accounting Estimates - amendments to IAS 8

●	International Tax Reform - Pillar Two Model Rules - amendments to IAS

●	Deferred Tax related to Assets and Liabilities arising from a Single Transaction - amendments to IAS 12

●	Disclosure of Accounting Policies - Amendments to IAS 1 and IFRS Accounting Standards Practice Statement 2

The amendments listed above did not have any impact on the amounts recognised in prior periods and are not expected to significantly affect the current or future periods.

ii) Standards, amendments to published standards and interpretations that are not yet effective and have not been early adopted by the Company

●	Amendments to IFRS Accounting Standards 10 and IFRS Accounting Standards 28 - Sale or Contribution of Assets between an Investor and its Associate or Joint Venture

●	Amendments to IFRS Accounting Standards 1 - Classification of Liabilities as Current or Non-current

●	Amendments to IFRS Accounting Standards 7 and IFRS Accounting Standards 7 - Supplier Finance Arrangements

●	Amendments to IFRS Accounting Standards 16 - Lease Liability in a Sale and Leaseback

●	Amendments to IFRS Accounting Standards 18 – Presentation and Disclosure in Financial Statements

The amendments listed above have been published but are not mandatory for 31 March 2025 reporting periods and have not been early adopted by the Company. These amendments are not expected to have a material impact on the entity in the current or future reporting periods and on foreseeable future transactions.

3. Trade and Other Receivables

	Unaudited 31 March 2025		30 June 2024
	AUD$		AUD$
CURRENT
Related party-Loans Note 21		633,773		-
Trade receivables- Related parties Note 21		799,737		-
Trade receivables, net ⁽¹⁾		4,309,859		4,470,101
Total current trade and other receivables		5,743,369		4,470,101

(1)

Trade receivables are presented net of expected net credit loss of AUD$ 169,148 and AUD$ 138,000 at 31 March 2025 and 30 June 2024, respectively.

The carrying value of trade receivables is considered a reasonable approximation of fair value due to the short-term nature of the balances.

The maximum exposure to credit risk at the reporting date is the fair value of each class of receivable in the financial statements.

The table below presents the expected credit losses on trade receivables for the nine months ended 31 March 2025:

	Current sales			30 days			60 days			90 days and older			Total
	Unaudited
	Current sales			30 days			60 days			90 days and older			Total
Balance as at reporting date	$	3,053,569		$	442,745		$	277,998		$	704,695		$	4,479,007
Expected loss rate		2.64	%		3.97	%		4.86	%		8.16	%
ECL allowance	$	80,557		$	17,577		$	13,511		$	57,503		$	169,148

The table below presents the expected credit losses on trade receivables for the year ended 30 June 2024:

	Current sales			30 days			60 days			90 days and older			Total
Balance as at reporting date	$	1,937,078		$	704,576		$	1,047,911		$	918,536		$	4,608,101
Expected loss rate		0.75	%		2.27	%		4.86	%		6.16	%
ECL allowance	$	14,520		$	15,995		$	50,935		$	56,550		$	138,000

4. Inventories

Schedule of Inventories

	Unaudited 31 March 2025		30 June 2024
	AUD$		AUD$
CURRENT
Raw materials and consumables		3,435,553		5,678,351
Finished goods		481,031		466,787
Consumables		264,319		57,022
Total inventories		4,180,903		6,202,160

5. Property, plant and equipment

	Unaudited 31 March 2025			30 June 2024
	AUD$			AUD$
LAND AND BUILDINGS
Freehold land		-			-
At cost		312,377			312,377
Total Land		312,377			312,377
Buildings
At cost		5,490,655			5,490,655
Accumulated depreciation		( 1,258,088	)		( 1,155,138	)
Total buildings		4,232,567			4,335,517
Total land and buildings		4,544,944			4,647,894
PLANT AND EQUIPMENT
Plant and equipment
At cost		14,424,269			13,118,595
Accumulated depreciation		( 3,349,251	)		( 3,200,732	)
Total plant and equipment		11,075,018			9,917,863
Motor vehicles
At cost		84,136			84,136
Accumulated depreciation		( 55,591	)		( 45,354	)
Total motor vehicles		28,545			38,782
Office equipment
At cost		61,812			58,890
Accumulated depreciation		( 48,578	)		( 45,916	)
Total office equipment		13,234			12,974
Total plant and equipment		11,116,797			9,969,619
Total property, plant and equipment		15,661,741			14,617,513

(a)	Movements in carrying amounts of property, plant and equipment

Movement in the carrying amounts for each class of property, plant and equipment for the nine months ended 31 March 2025 and for the year ended 30 June 2024:

						Plant and			Motor			Office
	Land		Buildings			Equipment			Vehicles			Equipment			Total
	AUD$		AUD$			AUD$			AUD$			AUD$			AUD$
Nine Months Ended 31 March 2025
Balance at 30 June 2024		312,377		4,335,517			9,917,863			38,782			12,974			14,617,513
Additions		-		-			1,307,077			-			671			1,307,748
Re-class		-		-			( 1,403	)		-			1,403			-
Depreciation expense		-		( 102,950	)		( 148,519	)		( 10,237	)		( 1,814	)		( 263,520	)
Balance at 31 March 2025		312,377		4,232,567			11,075,018			28,545			13,234			15,661,741

	Land		Buildings			Plant and Equipment			Motor Vehicles			Office Equipment			Total
	AUD$		AUD$			AUD$			AUD$			AUD$			AUD$
Year ended 30 June 2024
Balance at 30 June 2023		312,377		4,472,783			5,743,013			-			14,419			10,542,592
Beginning balance		312,377		4,472,783			5,743,013			-			14,419			10,542,592
Additions		-		-			4,432,465			38,291			6,679			4,477,435
Reclassification		-		-			( 8,094	)		9,840			( 1,746	)		-
Depreciation expense		-		( 137,266	)		( 249,521	)		( 9,349	)		( 6,378	)		( 402,514	)
Balance at 30 June 2024		312,377		4,335,517			9,917,863			38,782			12,974			14,617,513
Ending balance		312,377		4,335,517			9,917,863			38,782			12,974			14,617,513

6 Other assets

	Unaudited 31 March 2025		30 June 2024
	AUD$		AUD$
CURRENT
Prepayments		93,420		-
Tax recoverable		275,711		-
Other current assets		233,555		201,830
Total non-financial assets		602,686		201,830

	31 March 2025		30 June 2024
	AUD$		AUD$
NON-CURRENT
Prepayment of equipment		-		429,841

7. Trade and Other Payables

Schedule of Trade Payables

	Unaudited 31 March 2025		30 June 2024
	AUD$		AUD$
CURRENT
Related parties – payable Note 21		297,419		589,166
Trade payables		8,727,636		9,866,518
Total trade and other payables		9,025,055		10,455,684

Trade and other payables including related party payables are unsecured, non-interest bearing and are normally settled within 30 days. The carrying value of trade and other payables is considered a reasonable approximation of fair value due to the short-term nature of the balances.

8. Borrowings

Secured bank loan

In Feb 2024, the Company obtained an AUD$ 14 million bank facility to fund the expansion of the Cootamundra facility. The Company has deployed the AUD$ 14 million bank facility as follows: (i) AUD$ 4 million was allocated for equipment finance, (ii) AUD$ 8 million for working capital to purchase canola seed with max trade advance tenor of 120 days with BBSY plus 1.5 % margin rate per annum, and (iii) AUD$ 2 million for interest only loan over three years with interest rate of variable base rate minus a margin of 3.48 % per annum for business growth and working capital related to the crushing plant’s expansion.

On February 14, 2024, the Company issued a note for an equipment loan to the Commonwealth Bank of Australia in an aggregate principal amount of AUD$ 4,000,000 (the “Secured Bank Loan”). The note has a term of 60 months and a variable interest rate of 7.95 %. The Secured Bank loan is payable in twenty (20) quarterly payments of AUD$ 244,643 , commencing on May 19, 2024. Commonwealth Bank of Australia, as senior lender, has a total of $ 2 million secured by first mortgages over the Company’s freehold land and buildings. The financial assets pledged as collateral represent a floating charge and cannot be disposed of without the consent of the financier.

Convertible Note

On February 29, 2024, the Company entered into Amendment No.3 to the Securities Purchase Agreement for the purchase and sale of Debentures and Warrants.

The following table summarizes outstanding borrowings as of 31 March 2025 and 30 June 2024:

Schedule of Borrowings

	Current		Non-Current		Total		Current		Non-Current		Total
	Unaudited 31 March 2025						30 June 2024
	AUD$						AUD$
	Current		Non-Current		Total		Current		Non-Current		Total

Equipment Finance secured bank loan		978,573		2,366,071		3,344,644		978,574		2,900,259		3,878,833
Interest only secured bank loan		-		2,107,418		2,107,418		-		2,151,651		2,151,651
Total secured bank loan		978,573		4,473,489		5,452,062		978,574		5,051,910		6,030,484
Convertible note, net of debt discount		1,651,041		-		1,651,041		1,181,953		-		1,181,953
Total		2,629,614		4,473,489		7,103,103		2,160,527		5,051,910		7,212,437

The future payments of the equipment finance secured bank loan as of 31 March 2025 were as follows:

Calendar year	AUD$
2025		733,930
2026		978,573
2027		978,573
2028		978,573
2029		244,643
Total payments outstanding		3,914,292
Less: accrued interest		( 569,648	)
Total equipment finance secured loan outstanding		3,344,644

The following table summarizes the outstanding Convertible Note as of 31 March 2025 and 30 June 2024:

	31 March 2025			30 June 2024
	AUD$			AUD$
Principal value of Convertible Note		1,935,347			1,874,574
Debt discount, net of amortization		( 284,306	)		( 692,621	)
Convertible Note		1,651,041			1,181,953

9. Issued Capital

There have been no movements or changes in issued capital since 30 June 2024.

10. Warrants

The Company accounts for the Public warrants, the Private Placement warrants, the Representative warrants, the Penny warrants, and the Arena Ordinary share warrants in accordance with the guidance contained in IAS 32 and IFRS 9 under which the Public warrants meet the criteria for equity treatment and are recorded as equity due to the settlement provision in the warrant agreement. In accordance with IAS 32 and IFRS 9, the Private Placement warrants, Representative warrants, the Penny warrants and Arena Ordinary share warrants (collectively the “Warrants”) are initially required to be classified as liability instruments in its entirety; therefore, the Warrants are required to be measured at fair value at each reporting period with changes in fair value recorded within earnings.

The following table presents the warrants outstanding and exercisable on 31 March 2025 and 30 June 2024:


Public warrants			9,000,000
Private Placement warrants			479,000
Representative warrants			450,000
Arena Ordinary share warrants			458,720
Total warrants			10,387,720

Public, Private, and Representative Warrants

As part of EDOC’s IPO, EDOC issued warrants to third-party investors where each whole warrant entitles the holder to purchase one share of the Company’s ordinary shares at an exercise price of USD$ 11.50 per share (the “Public Warrants”). Simultaneously with the closing of the IPO, EDOC completed the private sale of warrants where each warrant allows the holder to purchase one share of the Company’s ordinary shares at USD$ 11.50 per share. Additionally, the Company issued to the underwriters a warrant (“Representative’s Warrant) to purchase up to 450,000 Class A ordinary shares stock at an exercise price of USD$ 11.50 per share.

These warrants expire on the fifth anniversary of the Business Combination or earlier upon redemption or liquidation and are exercisable commencing 30 days after the Business Combination, provided that the Company has an effective registration statement under the Securities Act covering the ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder.

The Company may call the warrants for redemption (excluding the private warrants, and any outstanding Representative’s Warrants, and any warrants underlying units issued to the Sponsor, initial shareholders, officers, directors or their affiliates in payment of Working Capital Loans made to the Company), in whole and not in part, at a price of USD$ 0.01 per warrant:

	●	at any time while the warrants are exercisable,

	●	upon not less than 30 days’ prior written notice of redemption to each warrant holder,

	●	if, and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $ 18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30-trading day period ending on the third trading business day prior to the notice of redemption to warrant holders, and

	●	if, and only if, there is a current registration statement in effect with respect to the issuance of the Class A ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day until the date of redemption.

Arena Ordinary Share Warrants

In connection with the closing of the Business Combination, the Company closed the private placement, pursuant to the private offering rules under the Securities Act of 1933, as amended (the “Securities Act”), of the Arena Warrants and Debentures pursuant to the Securities Purchase Agreement dated August 23, 2023 between the Company, AOI, EDOC, certain AOI subsidiaries and Arena Investors, LP (the “PIPE Investors”) and executed the Arena Transaction Documents including the 10 % Original Issue Discount Secured Convertible Debenture, the Arena Warrant, the Registration Rights Agreement and related documents. The Ordinary Shares pursuant to the Arena Warrants grant the PIPE Investors the right to purchase the number of Ordinary Shares underlying the Warrants equal to 25 % of the total principal amount of the related Debenture purchased by the PIPE Investor on the applicable closing date divided by 92.5% of the average of the three (3) lowest daily VWAP of the Ordinary Shares for the ten (10) consecutive trading day period ended on the last trading day immediately preceding such closing date, subject to adjustment upon the occurrence of certain events as set forth in such Arena Warrant be exercisable at the exercise price set forth in the Arena Warrants, as may be adjusted pursuant to the terms of the Arena Warrants.

Penny Warrants

In connection with the Amendment No. 3 to the Securities Purchase Agreement the Company agrees that in the event that (w) the Company fails to achieve the transfer of all of Energreen’s equity interests in CQ Oilseeds to the Company such that CQ Oilseeds becomes a wholly-owned subsidiary of the Company on or prior to the Substantial Completion Date, (x) the Company fails to achieve the transfer of the Australian Crushing Plant Lease from Energreen to CQ Oilseeds on or prior to the Substantial Completion Date, (y) CQ Oilseeds fails to grant to the Purchaser a first priority security interest in all of its assets, free and clear of all other liens and encumbrances other than the first priority security interests of the Purchaser pursuant to the Australian CQ Oilseeds General Security Deed and the Australian Leasehold Mortgage on or prior to the Substantial Completion Date, on or prior to the Substantial Completion Date, and/or (z) any of CQ Oilseeds, Energreen, the Company or the Company fails to comply with, or breaches any of the covenants in any Transaction Document, then (i) the Company shall issue to the Purchaser a warrant to purchase ten million (10,000,000) Ordinary Shares at an exercise price of USD$0.01 per Ordinary Share (as the same may be amended, amended and restated or otherwise modified from time to time, a “Penny Warrant”) and (ii) the Company shall enter into a Registration Rights Agreement with the Purchaser providing registration rights with respect to the Underlying Shares issuable under the Penny Warrant with terms substantially similar to the terms provided in the First Registration Rights Agreement. The Penny Warrant shall, among other things, (i) provide for the purchase by the Purchaser of ten million (10,000,000) Ordinary Shares (the “Penny Warrant Shares”), subject to adjustment upon the occurrence of certain events as set forth in such Penny Warrant; (ii) be exercisable at a price of USD$0.01 per Ordinary Share; and (iii) be substantially in the form of Exhibit C attached hereto. The Company and AOI agree that, from time to time, upon written notice from the Purchaser, the Company shall provide and cause their Subsidiaries to provide the Purchaser with any information and documentation related to the progress of the construction of the CQ Oilseeds Facility as the Purchaser may request in its discretion .

11. Lease liabilities and right-of-use assets

The Company’s leases include rental of a solar power system and plant space.

Lease liabilities are secured by the related leased assets.

Solar power system lease

The solar power system lease has a term commencing on October 31, 2015 through October 31, 2035.

Land lease

The Company leases land in Cootamundra, Australia, where the oilseed processing plant and ancillary buildings accommodating the equipment and facilities are located. The Cootamundra land lease has a term commencing on January 1, 2023 through December 31, 2025. Balances of the right-of use assets and lease liabilities are set forth on the accompanying statement of financial position.

The following table shows the remaining contractual maturities of the Company’s lease liabilities and the right-of-use assets as of 31 March 2025 and 30 June 2024:

Right-of-use assets	Unaudited 31 March 2025			30 June 2024
At cost	$	1,347,718		$	1,347,718
Less accumulated amortisation		( 475,340	)		( 403,298	)
Total	$	872,378		$	944,420

	31 March 2025		30 June 2024
Lease liabilities
Within 1 year (Current)	$	89,109	$	89,109
After 1 year but within 2 years		80,750		80,750
After 2 years but within 5 years		224,930		224,930
After 5 years		506,833		573,667
Non-current		812,513		879,347
Total	$	901,622	$	968,456

12. Revenue

The Company derives its revenue principally from wholesale and retail sales of chemical free, non-GMO, sustainable edible oils and products derived from oilseeds. The Company derives revenue from the transfer of goods at a point in time. The table below shows the Company’s revenue disaggregated by product type.

	2025		2024
	Three Months Ended 31 March
	2025		2024
	AUD$		AUD$

Wholesale oils	$	2,295,898	$	1,817,091
High protein meals		2,300,636		1,556,865
Other sales		27,678		119,683
Toll crushing service		58,011		-
Retail oils		4,748,005		2,802,212
Total revenues	$	9,430,228	$	6,295,851

	2025		2024
	Nine Months Ended 31 March
	2025		2024
	AUD$		AUD$

Wholesale oils	$	6,732,108	$	8,029,899
High protein meals		7,647,279		7,514,787
Toll crushing service		58,011		222,095
Seeds		-		23,490
Other sales		96,094		319,954
Retail oils		15,630,452		9,876,561
Total revenues	$	30,163,944	$	25,986,786

13. Cost of Sales

Schedule of Cost of sales

	2025		2024
	Three Months Ended 31 March
	2025		2024
	AUD$		AUD$

Cost of finished goods	$	1,815,995	$	1,413,261
Cost of material		5,829,288		2,986,965
Direct labor		631,045		481,152
Freight and storage		324,498		589,684
Depreciation		83,823		130,755
Occupancy costs		147,711		79,739
Repairs and maintenance		32,293		10,854
Total cost of sales	$	8,864,653	$	5,692,410

	2025		2024
	Nine Months Ended 31 March
	2025		2024
	AUD$		AUD$

Cost of finished goods	$	6,153,704	$	4,129,874
Cost of material		17,058,568		12,822,389
Direct labor		1,778,451		1,551,132
Freight and storage		1,794,815		1,731,300
Depreciation		251,469		336,009
Occupancy costs		445,098		280,626
Repairs and maintenance		80,890		216,980
Total cost of sales	$	27,562,995	$	21,068,310

14. General and administrative expenses

	2025		2024
	Three Months Ended 31 March
	2025		2024
	AUD$		AUD$

Professional fees	$	132,040	$	173,748
Audit fee		107,129		-
Employee costs		42,373		34,174
Insurance		124,099		16,063
Other expenses		25,191		34,592
Subscriptions and dues		15,827		12,909
Management fee		105,169		75,000
Travel expenses		31,832		37,670
Depreciation		28,123		2,482
Technology costs		2,587		25,757
Occupancy costs		8,650		4,595
Security		2,302		2,269
Utilities		3,256		2,695
Total general and administrative expenses	$	628,578	$	421,954

	2025		2024
	Nine Months Ended 31 March
	2025		2024
	AUD$		AUD$

Professional fees	$	921,928	$	1,062,389
Audit fee		196,641		-
Employee costs		267,352		124,997
Insurance		398,817		102,431
Other expenses		242,301		180,679
Subscriptions and dues		29,566		79,974
Management fee		294,169		228,000
Travel expenses		145,916		68,256
Depreciation		60,077		4,369
Technology costs		6,573		38,864
Occupancy costs		21,745		18,612
Security		6,869		6,575
Utilities		8,468		5,947
Total general and administrative expenses	$	2,600,422	$	1,921,093

15. Selling and marketing expenses

	2025		2024
	Three Months Ended 31 March
	2025		2024
	AUD$		AUD$
Professional fees	$	14,517	$	15,000
Bad debts
Advertising and marketing expenses		55,505		-
Total selling and marketing expenses	$	70,022	$	15,000

	2025		2024
	Nine Months Ended 31 March
	2025		2024
	AUD$		AUD$
Professional fees	$	102,267	$	82,500
Bad debts		4,513		142,000
Advertising and marketing expenses		247,776		45,705
Total selling and marketing expenses	$	354,556	$	270,205

16. Other Income

Schedule of Other Income

	2025		2024
	Three Months Ended 31 March
	2025		2024
	AUD$		AUD$
Other income	$	22,724	$	36,958
Total other income	$	22,724	$	36,958

	2025		2024
	Nine Months Ended 31 March
	2025		2024
	AUD$		AUD$
Other income	$	86,253	$	79,785
Total other income	$	86,253	$	79,785

17. Key management personnel compensation

Key management personnel remuneration included within employee expenses for the three and nine months ended 31 March 2025 and 2024 is shown below:

	2025		2024
	Three Months Ended 31 March
	2025		2024
	AUD$		AUD$
Short-term employee benefits	$	72,169	$	90,000
Post-employment benefits		8,299		9,900
Total	$	80,468	$	99,900

	2025		2024
	Nine Months Ended 31 March
	2025		2024
	AUD$		AUD$
Short-term employee benefits	$	314,323	$	213,602
Post-employment benefits		36,147		23,160
Total	$	350,470	$	236,762

18. Finance Expenses

	2025		2024
	Three Months Ended 31 March
	2025		2024
	AUD$		AUD$
Amortization of debt discount	$	136,106	$	-
Realised and unrealised currency losses (gains)		19,748		( 15,956	)
Interest expense		315,384		178,216
Total finance expenses	$	471,238	$	162,260

	2025			2024
	Nine Months Ended 31 March
	2025			2024
	AUD$			AUD$
Amortization of debt discount	$	413,552		$	-
Realised and unrealised currency losses (gains)		( 4,292	)		( 38,583	)
Interest expense		871,168			423,442
Total finance expenses	$	1,280,428		$	384,859

19. (Loss) Earnings per share

(a) Basic (loss) earnings per share

	2025			2024		2025			2024
	Three Months Ended 31 March					Nine Months Ended 31 March
	2025			2024		2025			2024
	AUD$					AUD$
Total basic (loss) earnings per share attributable to the ordinary equity holders of the company		( 0.03	)		0.00		( 0.07	)		0.13

(b) Diluted (loss) earnings per share

	2025			2024		2025			2024
	Three Months Ended 31 March					Nine Months Ended 31 March
	2025			2024		2025			2024
	AUD$					AUD$
Total diluted (loss) earnings per share attributable to the ordinary equity holders of the company		( 0.03	)		0.00		( 0.07	)		0.13

(c) Weighted average number of shares used as the denominator

Three and Nine Months Ended

31 March 2025

Three and Nine Months Ended

31 March 2024

Weighted average number of ordinary shares used as the denominator in calculating basic earnings per share

23,224,102

18,646,643

Weighted average number of ordinary shares and potential ordinary shares used as the denominator in calculating diluted earnings per share

23,224,102

18,646,643

20. Cash Flow Information

(a)	Reconciliation of cash

Cash for the nine months ended 31 March 2025 and 2024 as shown in the consolidated statement of cash flows is reconciled to items in the consolidated statement of financial position as follows:

	31 March 2025		31 March 2024
	AUD$		AUD$
Cash and cash equivalents		1,435,123		938,198

(b) Reconciliation of result for the year to cashflows from operating activities

Reconciliation of net income to net cash provided by operating activities:


(Loss) Profit for the period	( 1,597,298	)	2,422,104
Non-cash flows in (loss) profit:
– Other operating non-cash items	50,158		12,787
– depreciation	311,546		364,004
– Amortization of debt discount	413,552		-
Changes in assets and liabilities:
– (increase)/decrease in trade and other receivables	( 1,273,268	)	3,033,400
– (increase)/decrease in other assets	( 580,866	)	( 1,133,313	)
– (increase)/decrease in inventories	2,021,257		( 3,517,356	)
– increase/(decrease) in trade and other payables	( 1,106,154	)	( 245,633	)
– increase/(decrease) in provisions	( 181,896	)	323,492
Cash flows from/(used in) operations	( 1,942,969	)	1,259,485

Non-cash investing and financing activities were as follows:

	31 March 2025		31 March 2024
Intangible asset		-		50,000
Accrued expenses and warrant liabilities assumed upon closing of the merger with EDOC		136,105		-
Property Plant & Equipment (PPE)
Prepayment for purchase of PPE in FY 2024 capitalised in Half year ended 31 December 2024		429,841		-
Payments made by related party for company’s accrued expenses		550,702		-

21. Related Parties

(a) The Company’s main related parties are as follows:

Key management personnel — refer to Note 17.

Other related parties include close family members of key management personnel and entities that are controlled or significantly influenced by those key management personnel or their close family members and American Physicians, LLC, shareholders from the Sponsor of EDOC.

(b) Transactions with related parties.

The following transactions occurred with related parties:

For the nine months ended 31 March 2025 and the year ended 30 June 2024 a related party loan is owed to JSKS Enterprises Pty Ltd., which is the trustee of Gary Seaton Family Trust, and interest rate charge is 6 % per annum. to be repaid within 12 months after the year end, and the remaining principal shall be repaid more than 12 months after the year end.

For the nine months ended 31 March 2025 and the year ended 30 June 2024 a related party loan is owed to Energreen Nutrition Australia Pty Ltd., which is controlled by Gary Seaton, and interest rate charge is 6 % per annum and expected to be repaid in full within 12 months after the year end.

For the nine months ended 31 March 2025 and the year ended 30 June 2024 the remaining related party loan relates to an interest free loan owed to CQ Oilseeds Pty Ltd.

	Purchases of Seed for the Three Months Ended 31 March 2025		Purchases of Oils for the Three Months Ended 31 March 2025		Sales of Meals for the Three Months Ended 31 March 2025		Other Sales for the Three Months Ended 31 March 2025		Management Fee for the Three Months Ended 31 March 2025		Lease for the Three Months Ended 31 March 2025
	AUD$		AUD$		AUD$		AUD$		AUD$		AUD$
Related parties
Energreen Nutrition Australia Pty Ltd.		2,166,559		-		1,173,032				93,000		5,363
Soon Soon Oilmills Sdn Bhd. *				374,819
Sunmania Pty Ltd.		-		-		-		777		-		21,000

	Purchases of Seed for the Nine Months Ended 31 March 2025		Purchases of Oils for the Nine Months Ended 31 March 2025		Sales of Meals for the Nine Months Ended 31 March 2025		Other Sales for the Nine Months Ended 31 March 2025		Management Fee for the Nine Months Ended 31 March 2025		Lease for the Nine Months Ended 31 March 2025
	AUD$		AUD$		AUD$		AUD$		AUD$		AUD$
Related parties
Energreen Nutrition Australia Pty Ltd.		7,222,239		678,506		4,290,895		217,909		264,000		7,968
Soon Soon Oilmills Sdn Bhd. *		-		723,714		-		11,368		-		-
Sunmania Pty Ltd.		-		-		-		11,424		-		56,000

Gary Seaton has a 20 % share of Soon Soon Oilmills Sdn Bhd.

(a)

Loans to/from related parties

The current loans are payable on demand and the non-current loans have a maturity date which is more than 12 months from the date of 31 March 2025.

	Current		Non-current			Total
	Balance
	as of 31 March 2025
	Current		Non-current			Total
	AUD$		AUD$			AUD$
Due to related parties
Energreen Nutrition Australia Pty Ltd. loan		7,161,361		989,473			8,150,834
JSKS Enterprises Pty Ltd. Loan		1,050,825		3,932,742	⁽¹⁾		4,983,567
CQ Oilseeds Pty Ltd. loan		-		59,371			59,371
Sunmania Pty Ltd loan		192,000		-			192,000
Total due to related parties		8,404,186		4,981,586			13,385,772
Due from Energreen Nutrition Australia Pty Ltd- payments on behalf (Note-3)		633,773		-			633,773

American Physicians LLC promissory note ⁽²⁾		993,180		273,676			1,266,856

Energreen Nutrition Australia Pty Ltd. accounts payable (Note 7)		282,019		-			282,019
Sunmania Pty Ltd- Accounts payable (Note 7)		15,400		-			15,400
Trade receivable- Energreen Nutrition (Note- 3)		799,737		-			799,737

The current loans are payable on demand and the non-current loans have a maturity date which is more than 12 months from the date of 30 June 2024.

	Total due to related parties, current			Total due to related parties, noncurrent		Total due to related parties
	Balance
	as of 30 June 2024
	Current			Non-current		Total
	AUD$			AUD$		AUD$
Due to related parties
Energreen Nutrition Australia Pty Ltd. loan		3,863,250			-		3,863,250
JSKS Enterprises Pty Ltd. Loan		100,925			4,431,136		4,532,061
CQ Oilseeds Pty Ltd. loan		-			59,371		59,371
Sunmania Pty Ltd loan		152,000			40,000		192,000
Less: Origin Food loan receivable		( 4,514	)		-		( 4,514	)
Total due to related parties		4,111,661			4,530,507		8,642,168

American Physicians LLC promissory note		968,216			273,676		1,241,892

Energreen Nutrition Australia Pty Ltd. accounts payable (Note 7)		589,166			-		589,166

	(1)	Includes $ 1,050,824 of accrued interest.

	(2)	Includes $ 24,964 of accrued interest.

Interest to Energreen Nutrition Australia Pty Ltd. was AUD$ 15,707 and AUD$ 49,560 for the nine months ended 31 March 2025 and 2024, respectively.

Promissory Notes

On March 21, 2024, the Company issued two promissory notes in the principal amounts of USD$ 450,000 (the “First Promissory Note”) and USD$ 500,000 (the “Second Promissory Note”) to American Physicians, LLC.

The First Promissory Note accrues interest on the principal outstanding from time to time at a rate per annum equal to term SOFR for the interest period commencing on March 21, 2024. Interest shall be calculated on the basis on a 360-day year and actual days elapsed. The First Promissory Note principal and accrued interest are due and payable as follows:

(i) USD$ 112,500 plus any accrued but unpaid interest shall be paid on September 21, 2024;

(ii) USD$ 112,500 plus any accrued but unpaid interest shall be paid on December 21, 2024;

(iii) USD$ 112,500 plus any accrued but unpaid interest shall be paid on March 21, 2025;

(iv) USD$ 112,500 plus any accrued but unpaid interest shall be paid on June 21, 2025.

As of 31 March 2025, and 30 June 2024, there was AUD$ 690,184 (USD$ 450,000 ) and AUD$ 690,184 (USD$ 450,000 ) outstanding under the First Promissory Note, respectively.

The Second Promissory Note accrues interest on the principal outstanding from time to time at a rate per annum equal to term SOFR for the interest period commencing on March 21, 2024. Interest shall be calculated on the basis on a 360-day year and actual days elapsed. The Second Promissory Note principal and accrued interest are due and payable as follows:

(i) USD$ 165,000 plus any accrued but unpaid interest shall be paid on June 21, 2025;

(ii) USD$ 165,000 plus any accrued but unpaid interest shall be paid on September 21, 2025;

(iii) Remaining balance plus any accrued but unpaid interest shall be paid on December 21, 2025.

As of 31 March 2025, and 30 June 2024, there was AUD$ 526,744 (USD$ 343,437 ) and AUD$ 526,744 (USD$ 343,437 ) outstanding under the Second Promissory Note.

Accrued interest on the First Promissory Note and the Second Promissory Note was AUD$ 49,928 and AUD$ 24,964 as of 31 March 2025 and 30 June 2024, respectively.

The following table summarizes the promissory notes – related party as of 31 March 2025 and 30 June 2024:

Unaudited

31 March 2025

30 June 2024

AUD$

Current

Non-Current

Total

Current

Non-Current

Total

Promissory notes – related party

1,040,641

273,676

1,314,317

968,216

273,676

1,241,892

22. Fair value measurement

A fair value measurement of a non-financial asset takes into account a market participant’s ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.

The Company uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximising the use of relevant observable inputs and minimising the use of unobservable inputs.

In addition, for financial reporting purposes, fair value measurements are categorised into Level 1, 2 or 3 based on the degree to which the inputs to the fair value measurement are observable and the significance of the inputs to the fair value measurement in its entirety, which are described as follows:

	●	Level 1: quoted market price (unadjusted) in an active market for identical assets or liabilities that the entity can access at the measurement date.

	●	Level 2: inputs other than quoted prices included within Level 1 that are observable for the asset or liability; either directly or indirectly.

	●	Level 3: inputs that are unobservable inputs for the asset or liability.

The carrying amounts of the financial assets and financial liabilities approximate their fair values.

The fair values of cash and cash equivalents, prepaid assets, accounts payable and accrued expenses are estimated to approximate the carrying values as of 31 March 2025 and 30 June 2024, due to the short maturities of such instruments.

The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis on 31 March 2025 and 30 June 2024, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

			31 March		30 June
Description:	Level		2025		2024
			AUD$		AUD$
Liabilities:
Warrant liability—Private and Representative Warrants		3		12,676		12,676
Warrant liability – Penny Warrants		3		146,730		146,730
Warrant liability – Arena Ordinary Share Warrants		3		79,207		79,207
Total				238,613		238,613

The Private Warrants, Representative’s Warrants, Penny Warrants, and Arena Ordinary Share Warrants are accounted for as liabilities and are measured at fair value as of each reporting period. Changes in the fair value of the Warrants are recorded in the statements of operations for each period.

The Private Warrants, Representative Warrants, Penny Warrants, and Arena Ordinary Share Warrants were valued using a Montel Carlo simulation model, which is considered to be a Level 3 fair value measurement. Inherent in an options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.

There were no transfers between Levels 1, 2 or 3 during the three and nine months ended 31 March 2025 and the year ended 30 June 2024.

The following table provides quantitative information regarding Level 3 fair value measurements for Private Warrants as of 31 March 2025 and 30 June 2024. The Representative Warrants were valued using similar information, except for the strike price which is USD$ 12 .

	31 March 2025 and 30 June 2024
	$USD
Exercise price	$	11.50
Share price	$	0.97
Volatility		54.9	%
Expected life		4.73
Risk-free rate		4.33	%
Dividend yield		-	%

The following table provides quantitative information regarding Level 3 fair value measurements for the Penny Warrants and the Arena Ordinary Share Warrants as of 31 March 2025 and 30 June 2024.

	31 March 2025 and			Initial value
	30 June 2024			April 8 2024
	$USD			$USD
Exercise price	92.5 % of average lowest daily VWAP during the 10 preceding trading days			92.5 % of average lowest daily VWAP during the 10 preceding trading days
Share price	$	0.97		$	1.43
Volatility		54.9	%		51.9	%
Expected life		4.83			5.0
Risk-free rate		4.33	%		4.43	%
Dividend yield		-	%		-	%

The following table presents a summary of the changes in the fair value of the Private Warrants Penny Warrants, and Arena Warrants, Level 3 liabilities, measured on a recurring basis.

	Private Placement		Representative		Arena Ordinary Share		Penny		Total Warrant Liabilities
	$AUD		$AUD		$AUD				$AUD
Fair value as of 30 June 2024	$	12,655	$	21	$	79,207	$	146,730	$	238,613
Change in fair value		-		-		-		-		-
Fair value as of 31 March 2025	$	12,655	$	21	$	79,207	$	146,730	$	238,613

There were no significant changes to fair values of above instruments from 30 June 2024 to 31 March 2025.

23. Commitments and Contingencies

In the opinion of the Directors, the Company did no t have any contingencies on 31 March 2025 and 30 June 2024.

Other Commitments

On March 21, 2024, the Company entered into a fee modification agreement (the “Agreement”) with I-Bankers Securities, Inc. (“IBS”) related to the fees owed to IBS at the closing of the Business Combination pursuant to the original retainer letter (the “Owed Amounts”), for which IBS provided financial representation to EDOC regarding the Business Combination. Pursuant to the Agreement, IBS agreed to accept a payment plan for the Owed Amounts as follows:

	(a)	USD$ 1,550,000 of the Owed Amounts were paid to IBS at the closing of the Business Combination directly out of the Trust Account.

	(b)	The remaining balance owed of USD$ 1,161,250 is to be paid after the closing of the Business Combination in up to three separate tranches (“Deferred Cash Payment Obligations”). The first payment is to be paid within three (3) business days of funding the second tranche of the Arena PIPE in an amount equal to at least 15% of that tranche, or USD$375,000. The second payment is to be paid within three (3) business days of funding of the third tranche of the Arena PIPE in an amount equal to at least 15% of that tranche, or USD$375,000. The balance is due at the Company’s discretion but at no time later than 16-months post Business Combination. The full amount of USD$ 1,161,250 shall be paid in full regardless of Arena PIPE funding and by no later than sixteen (16) months post-closing.

	(c)	Deferred Cash Payment Obligations shall be accelerated in the event the Company issues debt, equity, or other equity-linked securities in one or more public or private offerings (“Capital Event”). Upon the occurrence of a Capital Event the Company shall pay from the Proceeds of the applicable capital sources within no more than three (3) business days following the consummation of such Capital Event of at least twenty percent (20%) of the Proceeds, up to the amount of any then-outstanding Deferred Cash Payment Obligations.

As of 31 March 2025 and 30 June 2024, the Company has paid Nil and USD$ 1,550,000 , respectively of the Owed Amounts to IBS and AUD$ 1,781,058 and AUD$ 1,781,058 are outstanding and recorded in trade and other payables, respectively, in the accompanying statement of financial position.

In June 2024, the Company entered into a payment agreement with Ellenoff Grossman & Schole LLP (“EGS”) related to the fees owed to EGS at the closing of the Business Combination for which EGS provided legal representation to EDOC regarding the Business Combination. Pursuant to the agreement, the EGS agreed to reduce the amount owed by the Company by USD$ 250,000 to USD$ 2,100,000 to be paid in payments beginning in June 2024 and ending in December 2025. The Company agreed to pay monthly payments of USD$ 100,000 per month, with the exception of a payment of USD$ 200,000 in December 2024 and December 2025.

As of 31 March 2025, the Company has paid USD$ 1,100,000 and USD$ 750,000 is outstanding and recorded in trade and other payable in the accompanying consolidated statement of financial position.

24. Net Tangible Assets

Net tangible assets per ordinary share have been determined using the net assets on the consolidated statement of financial position adjusted for non-controlling interests, intangible assets and goodwill.

25. Events Occurring After the Reporting Date

The consolidated financial report was authorized for issue by the board of directors.

We have received conversion notice on 28th April 2025 from Arena Investors, LP ((the “PIPE Investors”) to convert 10 % discount convertible debentures for USD 150,000 at USD 0.6758 per share for total of 221,957 shares, which was executed, and shares were transferred on 20th May 2025 based on conversion notices.

The Board approved the conversion of JSKS loan amounting to AUD 4.9 million to be converted to 4,452,479 at USD 0.7241 per share, which was executed, and shares were transferred on 22nd May 2025, to meet the Shareholder equity requirement of USD 10,000,000

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References to the “Company,” “our,” “us” or “we” refer to Australian Oilseeds Holdings Ltd. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report on Form 10-Q (this “Quarterly Report”). Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” and “continue,” or the negative of such terms or other similar expressions. Such statements include, but are not limited to, possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this Form 10-Q. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Company Overview

The Company is a Cayman Islands exempted company that, directly and indirectly through its subsidiaries, is focused on the manufacture and sale of chemical free, non-GMO, sustainable edible oils and products derived from oilseeds. The Company believes that transitioning from a fossil fuel economy to a renewable and chemical free economy is the solution to many health problems the world is facing presently. To that end, the Company is committed to working with suppliers and customers to eliminate chemicals from the edible oil production and manufacturing systems to supply quality products such as non-GMO oilseeds and organic and non-organic food-grade oils to customers globally. Over the past 20 years, Australian Oilseeds Investments Pty Ltd., an Australian proprietary company (“AOI”) has grown to be the largest cold pressing oil plant in Australia, pressing strictly GMO free conventional and organic oilseeds.

Business Combination

On March 21, 2024 (the “Closing Date”), Australian Oilseeds Holdings Limited., a Cayman Islands exempted company (“Australian Oilseeds” or the “Company”), consummated the previously announced business combination pursuant to the Business Combination Agreement, dated as of December 5, 2022 (as amended on March 31, 2023 and December 7, 2023 (the “Business Combination Agreement”), between the Company, EDOC Acquisition Corp., a Cayman Islands exempted company (“EDOC”), American Physicians LLC, a Delaware limited liability company, in the capacity as the representative, from and after the Closing Date for the shareholders of Purchaser and the Company (other than the Sellers (as defined below)) in accordance with the terms and conditions of the Business Combination Agreement (the “Purchaser Representative”), AOI Merger Sub, a Cayman Islands exempted company and a wholly-owned subsidiary of the Company (“Merger Sub”), Australian Oilseeds Investments Pty Ltd., an Australian proprietary company (“AOI”), Gary Seaton, in his capacity as the representative for the Sellers, in accordance with the terms and conditions of the Business Combination Agreement (the “Seller Representative”), and each of the holders of AOI’s outstanding ordinary shares named on Annex I to the Business Combination Agreement (the “Primary Sellers”), as amended from time to time, to include subsequent parties that execute and deliver to Purchaser, the Company and AOI, a Joinder (the “Joining Sellers”), and the holders of AOI’s outstanding ordinary shares who are bound by the provisions of the Business Combination Agreement pursuant to the drag-along rights set forth in AOI’s memorandum and articles of association (the “Drag-Along Sellers,” and collectively with the Joining Sellers, the “Sellers”). The transactions contemplated by the Business Combination Agreement are referred to herein as the “Business Combination.”

Pursuant to the Business Combination Agreement, on the Closing Date, EDOC merged with and into Merger Sub, with EDOC continuing as the surviving entity (the “Merger”), as a result of which, EDOC became a wholly-owned subsidiary of the Company, and each issued and outstanding security of EDOC prior to the Closing Date was cancelled in exchange for the receipt of substantially identical securities of the Company. Also on the Closing Date, the Company acquired all of the issued and outstanding ordinary shares of AOI (the “Purchased Shares”) from the Sellers in exchange for the Company’s ordinary shares (“Company Ordinary Shares”) par value $0.0001 per share (the “Share Exchange”). More specifically, pursuant to the Business Combination Agreement, at the effective time of the Business Combination (the “Effective Time”):

	(i)	Each holder of EDOC pre-transaction privately-held Class A ordinary shares and the Class B ordinary share (the “EDOC Ordinary Shares”) received Company Ordinary Shares, which are listed under the ticker “COOT” (less 200,000 Class A ordinary shares that were forfeited by EDOC back to the Company);

	(ii)	Each holder of AOI ordinary shares received Company Ordinary Shares on a one-for-one basis (the “Exchange Shares”);

	(iii)	Each holder of EDOC’s public Class A ordinary shares received Company Ordinary Shares on a one-for-one basis;

	(iv)	EDOC’s warrants terminated and were exchanged for warrants of the Company (the “Warrants”), which Warrants are listed on the Nasdaq under “COOTW”;
	(v)	Each holder of EDOC’s rights (the “Rights”) received 1/10 of a Company Ordinary Share for each such Right, as set forth herein;

	(vi)	EDOC’s Rights were no longer be traded;

	(vii)	EDOC’s 479,000 placement units (“Placement Units”) were exchanged for Company Ordinary Shares and Warrants of the Company; and

	(viii)	EDOC’ $1,500,000 of convertible promissory notes that were convertible at Closing into Company Ordinary Shares (“Convertible Shares”) and warrants (“Convertible Warrants”).

In connection with the closing of the Business Combination, EDOC and/or the Company entered into or amended, as applicable, certain agreements with their vendors or service providers, including the underwriter in EDOC’s IPO, to pay various business combination transaction expenses otherwise due at Closing, including deferral agreements with vendors or service providers, requiring deferred cash payments by the registrant to such parties to be satisfied over specified time periods after Closing, and certain other fee modification agreements with vendors or service providers pursuant to which such parties received newly issued Ordinary Shares at Closing and/or deferred cash payments (or a combination of both). Pursuant to such agreements, an aggregate of 840,891 Company Ordinary Shares (694,391 to Arc Group Limited and 146,500 to I-Bankers Securities, Inc.) were issued to such providers.

In addition, in connection with the closing of the Business Combination, the Company closed the private placement of the Arena Warrants and Debentures pursuant to the Securities Purchase Agreement dated August 23, 2023 between the Company, AOI, EDOC, certain AOI subsidiaries and Arena Investors, LP (the “PIPE Investors”) and executed the Arena Transaction Documents including the 10% Original Issue Discount Secured Convertible Debenture, the Arena Warrant, the Registration Rights Agreement and related documents.

In addition, at the Closing, the Company, the Primary Sellers, the Purchaser Representative, the Seller Representative and the Escrow Agent entered into an escrow agreement (the “Subscription Escrow Agreement”), pursuant to which a number of Exchange Shares equal to 15% of the estimated Exchange Consideration issuable to the Sellers at the Closing (such Exchange Shares, together with any equity securities paid as dividends or distributions with respect to such shares or into which such shares are exchanged or converted the “Escrow Shares”) are subject to the restrictions of the Escrow Agreement and shall be held by the Escrow Agent, along with any dividends, distributions or income thereon (together with the Escrow Shares, the “Escrow Property”) in a segregated account (the “Escrow Account”) and disbursed in accordance with the Business Combination Agreement and the Subscription Escrow Agreement. The Escrow Shares will be held in the Escrow Account for a period of 12 months after the Closing and shall be the sole and exclusive source of payment for any post-Closing purchase price adjustment and for any post-closing indemnification claims (other than certain fraud claims and breaches of AOI and the Sellers’ fundamental representations, as in the Business Combination Agreement). At the 12-month anniversary of the Closing, on March 21, 2025, all remaining Escrow Property will be released to the Sellers in accordance with the Business Combination Agreement. However, the amount of Escrow Property equal to the value of any pending and unresolved claims will remain in the Escrow Account until finally resolved.

The transaction was unanimously approved by the board of directors of EDOC and was approved at the extraordinary general meeting of EDOC’s shareholders held on March 6, 2024 (the “Special Meeting”). EDOC’s shareholders also voted to approve all other proposals presented at the Special Meeting. As a result of the Business Combination, AOI and EDOC became wholly-owned direct subsidiaries of the Company. On March 22, 2024, the Ordinary Shares and public warrants of the Company (the “Public Warrants”) commenced trading on the Nasdaq Global Market, or “Nasdaq,” under the symbols “COOT” and “COOTW,” respectively.

Key Components of Consolidated Statements of Profit or Loss and Other Comprehensive Income

Sales revenue

Revenues consist of sales of edible oils, sales of protein meals and tolling revenue from oilseeds crushing activities. The Company’s edible oil sales comprise of two segments: sales of bulk oils to wholesalers who use it as food ingredients or white labelling; sales of packaged oils as the company’s own branding to major supermarket channels. Sales of protein meals are bulk sales and mainly distributed to local farmers and feedlots as protein supplements. Tolling revenue is the service charge fee of crushing oilseeds to produce edible oils and protein meals.

Cost of sales

Cost of sales consist of costs directly related to the manufacturing process of edible oils and protein meals. It includes the cost of materials which mainly consist of the procurement cost of non-GMO canola seeds, canola seeds freight and storage cost from the suppliers, direct labor in the factory plant, occupancy costs of energy consumption of manufacturing process, depreciation expense of the crushing plant and relevant equipment and vehicles, and repairs and maintenance.

General and Administrative expenses

General and administrative expenses primarily consist of personnel expenses, professional fees, occupancy costs, depreciation expense, insurance expense, management fees, office expenses, security expenses, travel expenses, staff training expenses, utilities expenses, and subscription and dues expenses.

Sales and marketing expenses

Sales and marketing expenses primarily consist of sales directors’ salaries and supermarket promotion activities.

Other income

Other income primarily consists of fuel tax credit and recovery cost of freight and overdue interest.

Finance expenses

Finance expenses consist of interest paid related to bank loan and facility interest, related party loan interest and foreign exchange gain or loss.

Change in fair value of warrant liabilities

This consists of the change in fair value of certain warrant liabilities.

Results of Operations

The following selected consolidated financial data are derived from the unaudited financial statements of the Company for the three and nine months ended 31 March 2025 and 2024 and should be read in conjunction with our consolidated financial statements, the related notes and the rest of the section of this Report entitled “Key Components of Consolidated Statements of Operations.” The historical results are not necessarily indicative of the results of future operations.

Three Months and Nine months Ended 31 March 2025 Compared to the Three Months and Nine months Ended 31 March 2024

The following tables set forth our Consolidated Statements of Operations data for the periods presented:

	Note		THREE MONTHS ENDED MAR 2025			THREE MONTHS ENDED MAR 2024			NINE MONTHS ENDED MAR 2025			NINE MONTHS ENDED MAR 2024
			AUD$			AUD$			AUD$			AUD$
Sales revenue		12		9,430,228			6,295,851			30,163,944			25,986,786
Cost of sales		13		(8,864,653	)		(5,692,410	)		(27,562,995	)		(21,068,310
Gross profit				565,575			603,441			2,600,949			4,918,476
General and administrative expenses		14		(628,578	)		(421,954	)		(2,600,422	)		(1,921,093
Selling and marketing expenses		15		(70,022	)		(15,000	)		(354,556	)		(270,205
Other income		16		22,724			36,958			86,253			79,785
Operating (loss)/profit				(110,301	)		203,445			(267,776	)		2,806,963
Finance expenses		18		(471,238	)		(162,260	)		(1,280,428	)		(384,859
(Loss) Profit before income tax				(581,539	)		41,185			(1,548,204	)		2,422,104
Income tax expense				(49,094	)		-			(49,094	)		-
(Loss) Profit for the period				(630,633	)		41,185			(1,597,298	)		2,422,104
Other comprehensive income for the period, net of tax				-			-			-			-
Total comprehensive (loss) income				(630,633	)		41,185			(1,597,298	)		2,422,104
(Loss) Profit attributable to:
Members of the parent entity				(559,758	)		26,324			(1,501,719	)		1,858,356
Non-controlling interest				(70,875	)		14,861			(95,579	)		563,748
Total (Loss) Income				(630,633	)		41,185			(1,597,298	)		2,422,104

Revenue

	Three Months Ended 31 March (AUD)
	2025		2024		Change		Change %

Total revenue	$	9,430,228	$	6,295,851	$	3,134,377		49.8	%

Sales revenue increased by AUD$3.1 million or 49.8% to AUD$9.4 million for the three-month period ended on 31 March 2025, compared to AUD$6.3 million for the three-month period ended 31 March 2024, primarily due to increase in sale of our retail oils segment and sales contracts procured with some of supermarkets in Australia.

The following table summarizes the Company’s revenues disaggregated by product category:

	Three Months Ended 31 March (AUD)
	2025		2024		Change			Change %

Wholesale oils	$	2,295,898	$	1,817,091	$	478,807			26.4	%
High protein meals		2,300,636		1,556,865		743,771			47.8	%
Toll crushing service		58,011		-		58,011			100	%
Other sales		27,678		119,683		(92,005	)		(76.9	)%
Retail oils		4,748,005		2,802,212		1,945,793			69.4	%
Total revenues	$	9,430,228	$	6,295,851	$	3,134,377			49.8	%

Wholesale oils represented 24.3% of our revenue for the three months ended 31 March 2025, compared to 28.9% for the three months ended 31 March 2024, and increased AUD$0.5 million, as compared to the prior year. Retail oils represented 50.3% of our revenue for the three months ended 31 March 2025, compared to 44.5% for the three months ended 31 March 2024, and increased AUD$1.9 million, as compared to the prior period. The primary driver for the revenue increase in retail oils for the three months ended 31 March 2025 compared to the previous period was due to the Company securing three supply contracts to supply 15 Costco Australia stores, 1,050 Woolworth Supermarkets national stores and 850 Coles supermarket stores throughout Australia. The Company also developed four new SKU to target the retail consumers from 2024 through integrated marketing campaign with the supermarkets. As the Company focused on developing the retail market during the current quarter of 2024, the whole sales proportion became smaller than last year quarter. High protein meals for the feed industry represented 24.3% of our revenue for the three months ended 31 March 2025, compared to 24.7% for the three months ended 31 March 2024, and increased AUD$0.7 million as compared to the prior period. The primary driver for the revenue increase in high protein meals for the three months ended 31 March 2025, compared to the previous period was a decrease of sales price of protein meal due to Australia experiencing good rainfall year caused less demand of protein meal in feedlot market.

	Nine Months Ended 31 March (AUD)
	2025		2024		Change		Change %

Total revenue	$	30,163,944	$	25,986,786	$	4,177,158		16.1	%

Sales revenue increased by AUD$4.1 million or 16.1% to AUD$30.1 million for the nine-month period ended on 31 March 2025, compared to AUD$25.9 million for the nine-month period ended 31 March 2024, primarily sales contracts procured with some of supermarkets in Australia.

	Nine Months Ended 31 March (AUD)
	2025		2024		Change			Change %

Wholesale oils	$	6,732,108	$	8,029,899	$	(1,297,791	)		(16.1	)%
High protein meals		7,647,279		7,514,787		132,492			1.8	%
Toll crushing service		58,011		222,095		(164,084	)		(73.9	)%
Seeds		-		23,490		(23,490	)
Other sales		96,094		319,954		(223,860	)		(69.9	)%
Retail oils		15,630,452		9,876,561		5,753,891			58.2	%
Total revenues	$	30,163,944	$	25,986,786	$	4,177,158			16.1	%

Wholesale oils represented 22.3% of our revenue for the nine months ended 31 March 2025, compared to 30.9% for the nine months ended 31 March 2024, and decreased AUD$1.2 million, as compared to the prior year. Retail oils represented 51.8% of our revenue for the nine months ended 31 March 2025, compared to 38.0% for the nine months ended 31 March 2024, and increased AUD$5.7 million, as compared to the prior period. The primary driver for the revenue increase in retail oils for the nine months ended 31 March 2025 compared to the previous period was due to the Company securing three supply contracts to supply 15 Costco Australia stores, 1,050 Woolworth Supermarkets national stores and 850 Coles supermarket stores throughout Australia. The Company also developed four new SKU to target the retail consumers from 2024 through integrated marketing campaign with the supermarkets. As the Company focused on developing the retail market during the current quarter of 2024, the whole sales proportion became smaller than last year quarter. High protein meals for the feed industry represented 25.3% of our revenue for the nine months ended 31 March 2025, compared to 28.9% for the nine months ended 31 March 2024, and increased AUD$0.1 million as compared to the prior period.

Other sales represent a small portion of our revenue and represented 0.3% of the revenue for the three months ended 31 March 2025, compared to 1.9% for the three months ended 31 March 2024, a decrease of AUD$0.1 million for the three months ended 31 March 2025, as compared to the three months ended 31 March 2024.

Cost of Sales

	Three Months Ended 31 March (AUD)
	2025		2024		Change			Change %

Cost of finished goods	$	1,815,995	$	1,413,261	$	402,734			28.2	%
Cost of material		5,829,288	$	2,986,965	$	2,842,323			95.2	%
Labor costs		631,045		481,152		149,893			31.2	%
Freight and storage		324,498		589,684		(265,186	)		(45.0	)%
Depreciation		83,823		130,755		(46,932	)		(35.9	)%
Occupancy costs		147,711		79,739		67,972			85.2	%
Repairs and maintenance		32,293		10,854		21,439			197.5	%
Total cost of sales	$	8,864,653	$	5,692,410	$	3,172,243			55.7	%

The cost of sales for the three months ended 31 March 2025 was AUD$8.9 million, an increase of AUD$3.0 million, or 55.7% as compared to the three months ended 31 March 2024. The primary reason for the increase was caused by cost of material, increase in cost of packaging material due to increase in retail sales, and labor cost increase during the quarter.

	Nine Months Ended 31 March (AUD)
	2025		2024		Change			Change %

Cost of finished goods	$	6,153,704	$	4,129,874	$	2,023,830			49.0	%
Cost of material		17,058,568		12,822,389		4,236,179			33.0	%
Labor costs		1,778,451		1,551,132		227,319			14.6	%
Freight and storage		1,794,815		1,731,300		63,515			3.7	%
Depreciation		251,469		336,009		(84,540	)		(25.2	)%
Occupancy costs		445,098		280,626		164,472			58.6	%
Repairs and maintenance		80,890		216,980		(136,090	)		(62.7	)%
Total cost of sales	$	27,562,995	$	21,068,310	$	6,494,685			30.8	%

The cost of sales for the nine months ended 31 March 2025 was AUD$27.5 million, an increase of AUD$6.5 million, or 30.8% as compared to the nine months ended 31 March 2024. The primary reason for the increase was caused by cost of material (canola seed), increase in cost of packaging material due to increase in retail sales, and labor cost increase during the quarter.

General and administrative expenses

	Three Months Ended 31 March (AUD)
	2025		2024		Change		Change %

General and administrative expenses	$	628,578	$	421,954	$	206,624		49.0	%

General and administrative expenses for the three months ended 31 March 2025 were AUD$0.6 million, an increase of AUD$0.2 million, or 49.0%, compared to the three months ended 31 March 2024. This increase was primarily due to increase in audit fee AUD$0.1 million and insurance AUD$0.1 million.

	Nine Months Ended 31 March (AUD)
	2025		2024		Change		Change %

General and administrative expenses	$	2,600,422	$	1,921,093	$	679,329		35.3	%

General and administrative expenses for the nine months ended 31 March 2025 were AUD$2.6 million, an increase of AUD$0.7 million, or 35.3%, compared to the nine months ended 31 March 2024. This increase was primarily due to increase in audit fee AUD$0.2 million, insurance AUD$0.3 million and employee cost AUD$0.1 million.

Selling and marketing expenses

	Three Months Ended 31 March (AUD)
	2025		2024		Change		Change %

Selling and marketing expenses	$	70,022	$	15,000	$	55,022		366.8	%

Selling and marketing expenses for the three months ended 31 March 2025 were AUD$0.07 million, an increase of AUD$0.06 million, or 366.8% compared to the three months ended 31 March 2024. This increase was due to additional marketing expenses incurred to promote brand awareness.

	Nine Months Ended 31 March (AUD)
	2025		2024		Change		Change %

Selling and marketing expenses	$	354,556	$	270,205	$	84,351		31.2	%

Selling and marketing expenses for the nine months ended 31 March 2025 were AUD$0.3 million, an increase of AUD$0.08 million, or 31.2% compared to the nine months ended 31 March 2024. This increase was due to additional marketing expenses incurred to promote brand awareness and was partially offset by decrease in bad debts.

Other Income

	Three Months Ended 31 March (AUD)
	2025		2024		Change			Change %

Other income	$	22,724	$	36,958	$	(14,234	)		(38.5	)%

Other income for the three months ended 31 March 2025 was AUD$0.02 million, an decrease of AUD$0.01 million, or 38.5% compared to the three months ended 31 March 2024. This decrease was primarily due to interest charges to customers.

Other Income

	Nine Months Ended 31 March (AUD)
	2025		2024		Change		Change %

Other income	$	86,253	$	79,785	$	6,468		8.1	%

Other income for the nine months ended 31 March 2025 was AUD$0.08 million, there was a slight increase in other income is due to interest charged to customers compared to nine months ended 31 March 2024.

Finance expenses

	Three Months Ended 31 March (AUD)
	2025		2024		Change		Change %

Finance expenses	$	471,238	$	162,260	$	308,978		190.4	%

Finance expenses increased by AUD$0.3 million or 190.4% to AUD$0.5 million for the three months ended 31 March 2025 compared to AUD$0.1 million for the three months ended on 31 March 2024, primarily due to the fact that the Company began to repay the AUD$4 million asset finance provided by Commonwealth Bank of Australia to expand the existing Cootamundra Oilseeds factory plant, the amortization of the convertible note discount of AUD$0.1 million and the interest accrual on utilization of trade finance facility from Commonwealth Bank of Australia.

	Nine Months Ended 31 March (AUD)
	2025		2024		Change		Change %

Finance expenses	$	1,280,428	$	384,859	$	895,569		232.7	%

Finance expenses increased by AUD$0.9 million or 232.7% to AUD$1.2 million for the nine months ended 31 March 2025 compared to AUD$0.4 million for the nine months ended on 31 March 2024, primarily due increased Interest expenses AUD$0.4 million to the fact that the Company began to repay the AUD$4 million asset finance provided by Commonwealth Bank of Australia to expand the existing Cootamundra Oilseeds factory plant, the amortization of the convertible note discount of AUD$0.4 million.

Liquidity and Capital Resources

As of 31 March 2025, our principal sources of liquidity were net proceeds received related to the Business Combination and cash received from customers.

The Company incurred a loss after income tax for the 3 months ended 31 March 2025 of AUD$630,633 (31 March 2024: Profit AUD$41,185) and for nine months ended 31 March 2025 a loss of AUD$1,597,298 (31 March 2024: Profit AUD$2,422,104). The Company was in a net current liability position of AUD$9,622,311 as of 31 March 2025 (30 June 2024: AUD$6,965,530). Net cash outflow from operating activities was AUD$1,942,969 for the nine months ended 31 March 2025 (31 March 2024: AUD$1,259,485).

As at 31 March 2025 and 30 June 2024, the consolidated entity had cash in hand and at bank of AUD$1,435,123 and AUD$514,140, respectively.

The financial statements have been prepared on a going-concern basis, which contemplates continuity of normal activities and realization of assets and settlement of liabilities in the normal course of business.

We conducted a reverse acquisition of EDOC Acquisition Limited “ADOC” through the deSPAC on 21 March 2024, the consolidated entity assumed AUD$5,248,824 of previously unpaid transaction costs charged by service providers of “ADOC”, AUD$1,216,928 promissory notes to American Physicians LLC and a AUD$1,533,742 convertible note to PIPE Investor ARENA as of 30 June 2024.

Therefore, our ability to continue its business activities as a going concern is dependent upon us deriving sufficient cash from the business operation and being able to draw down additional long-term debt from the senior debt provider, Commonwealth Bank of Australia, who has provided a total facility loan of AUD$14 million with unused facilities as at 31 March 2025 of AUD$8 million. In addition, we also have the ability to draw down an additional US$6 million of redeemable debentures from the existing PIPE investors or the executed US$50 million equity line of credit (ELOC) once the Company lodges the registration statement of the ELOC. The Company has determined that the Company’s sources of liquidity will be sufficient to meet the Company’s financing requirements for the one-year period from the issuance of its consolidated financial statements.

The following table shows the net cash and cash equivalents provided by (used in) operating activities, net cash and cash equivalents used in investing activities, and net cash and cash equivalents provided by financing activities during the periods presented:

	Nine Months Ended 31 March (AUD)
	2025			2024
Net cash (used in) provided by
Operating activities		(1,942,969	)		1,259,485
Investing activities		(901,918	)		(3,302,050	)
Financing Activities		3,765,870			2,859,489

Operating Activities

As of 31 March 2025, our net cash and cash equivalents used in operating activities consists primarily of AUD$28,976,930 of cash receipts from customers and AUD$29,894,989 of payments to suppliers and employees.

By comparison, the Company’s net cash and cash equivalents provided by operating activities as of 31 March 2024, consists primarily of AUD$29,099,972 of cash receipts from customers and AUD$27,011,986 of payments to suppliers and employees.

Investing Activities

Our investing activities have consisted primarily of property and equipment purchases.

Net cash and cash equivalents used in investing activities during the nine months ended 31 March 2025, consisted of AUD$901,918 of purchased property and equipment.

By comparison, the Company’s net cash and cash equivalents used in investing activities during the nine months ended 31 March 2024, consisting primarily of AUD$3,302,050 of purchased property and equipment.

Financing Activities

Net cash flows provided by financing activities were AUD$3,765,870 for the nine months ended 31 March 2025, consisted primarily of net cash inflow related party loans AUD$4,556,838, trade facility borrowings AUD$1,971,103 and repayment of loan AUD$2,712,831.

By comparison, the Company’s net cash flows provided by financing activities was AUD$2,859,489 for the nine months ended 31 March 2024, which consisted primarily of the net cash inflow from the related party loans AUD$945,189 and net cash inflow from trade facility borrowings of AUD$1,986,610.

Non-IFRS Accounting Standards Financial Measure

In addition to providing financial measurements based on IFRS Accounting Standards, we provide an additional financial metric that is not prepared in accordance with IFRS Accounting Standards, or non-IFRS Accounting Standards financial measure. We use this non-IFRS Accounting Standards financial measure, in addition to IFRS Accounting Standards financial measures, to understand and compare operating results across accounting periods, for financial and operational decision making, for planning and forecasting purposes, to measure executive compensation, and to evaluate our financial performance. This non-IFRS Accounting Standards financial measure is Adjusted EBITDA, as discussed below.

We believe that this non-IFRS Accounting Standards financial measure reflects our ongoing business in a manner that allows for meaningful comparisons and analysis of trends in the business, as it facilitates comparing financial results across accounting periods and to those of peer companies. We also believe that this non-IFRS Accounting Standards financial measure enables investors to evaluate our operating results and future prospects in the same manner as we do. This non-IFRS Accounting Standards financial measure may exclude expenses and gains that may be unusual in nature, infrequent, or not reflective of our ongoing operating results.

The non-IFRS Accounting Standards financial measure does not replace the presentation of our IFRS Accounting Standards financial measures and should only be used as a supplement to, not as a substitute for, our financial results presented in accordance with IFRS Accounting Standards.

We consider Adjusted EBITDA to be an important indicator of the operational strength and performance of our business and a good measure of our historical operating trends. Adjusted EBITDA eliminates items that we do not consider to be part of our core operations. We define Adjusted EBITDA as IFRS Accounting Standards net loss excluding the following items: interest income; income taxes; depreciation and amortization of tangible and intangible assets; unit and stock-based compensation; Business Combination transaction expenses; and other non-recurring items that may arise from time to time.

The non-IFRS Accounting Standards adjustments, and our basis for excluding them from our non-IFRS Accounting Standards financial measure, are outlined below:

●

Unit and Stock-based compensation – Although unit and stock-based compensation is an important aspect of the compensation paid to our employees, the grant date fair value varies based on the derived stock price at the time of grant, varying valuation methodologies, subjective assumptions, and the variety of award types. This makes the comparison of our current financial results to previous and future periods difficult to interpret; therefore, we believe it is useful to exclude unit and stock-based compensation from our non-IFRS Accounting Standards financial measures to highlight the performance of our business and to be consistent with the way many investors evaluate our performance and compare our operating results to peer companies.

The following table reconciles IFRS Accounting Standards net profit to Adjusted EBITDA during the periods presented (in thousands):

	Nine Months Ended 31 March 2025			Nine Months Ended 31 March 2024
Net (Loss) Profit	$	(1,597	)	$	2,422
Interest Expense	$	1,280		$	385
Depreciation and amortization	$	312		$	340
Adjusted EBITDA	$			$

	Three Months Ended 31 March 2025			Three Months Ended 31 March 2024
Net (Loss) Profit	$	(631	)	$	41
Interest Expense	$	471		$	162
Depreciation and amortization	$	112		$	133
Adjusted EBITDA	$			$

Contractual Obligations and Commitments and Liquidity Outlook

Our ability to continue as a going concern is dependent upon our ability to generate cashflows from operations, which projected to AUD 2.4 million net profit before tax from July 2026 to June 2026 subject to market and weather condition in our domestic and export markets, and draw down additional long-term debt from the senior debt provider, Commonwealth Bank of Australia, who has provided a total facility loan of AUD$14,000,000 with unused facilities as at 31 March 2025 of AUD$8,000,000 and draw down an additional US$6 million of redeemable debentures from the existing PIPE investors or the executed US$50 million equity line of credit (ELOC) once the Company lodges the registration statement of the ELOC. The Company has determined that the Company’s sources of liquidity will be sufficient to meet the Company’s financing requirements for the one year period from the issuance of its unaudited condensed consolidated financial statements but there can no assurance these sources are sufficient to fund our capital expenditures, working capital and other cash requirements in the long term. There can be no assurance that the steps management is taking will be successful.

Our future capital requirements will also depend on additional factors, including our growth rate, the timing and extent of spending to support research and development efforts, the expansion of sales and marketing activities, the introduction of new and enhanced product and service offerings, and the cost of any future acquisitions of technology or businesses. In the event that additional financing is required from outside sources, we may be unable to raise the funds on acceptable terms, if at all.

Material Accounting Policies and Estimates

Our management’s discussion and analysis of financial condition and results of operations is based on our consolidated financial statements which have been prepared in accordance with IFRS Accounting Standards. In preparing our financial statements, we make estimates, assumptions, and judgments that can have a significant impact on our reported revenue, results of operations, and net income or loss, as well as on the value of certain assets and liabilities on our balance sheet during and as of the reporting periods. These estimates, assumptions, and judgments are necessary because future events and their effects on our results and the value of our assets cannot be determined with certainty and are based on our historical experience and on other assumptions that we believe to be reasonable under the circumstances. These estimates may change as new events occur or additional information is obtained, and we may periodically be faced with uncertainties, the outcomes of which are not within our control and may not be known for a prolonged period of time. Because the use of estimates is inherent in the financial reporting process, actual results could differ from those estimates.

We believe that the assumptions and estimates associated with the following material accounting policies involve significant judgment and thus have the most significant potential impact on our Consolidated Financial Statements.

Revenue Recognition

We generate revenue from the sale of products and services. There has been no change in our revenue recognition policies is included in the Form 10-K for the financial year ended 30 June 2024.

Although most of our sales agreements contain standard terms and conditions, certain agreements contain multiple performance obligations or non-standard terms and conditions. For customer contracts that contain more than one performance obligation, we allocate the total transaction consideration to each performance obligation based on the relative stand-alone selling price of each performance obligation within the contract. We rely on either observable standalone sales or an expected cost plus a margin approach to determine the standalone selling price of offerings, depending on the nature of the performance obligation.

For contracts with customers entered into during the three months ended 31 March 2025 and 2024, revenue from the sales of our products increased by AUD$3.1 million or 48.9% to AUD$9.4 million for the three months ended on 31 March 2025 compared to AUD$6.3 million for the three months ended 31 March 2024, primarily due to favorable market conditions resulting from an increase in the demand for cold pressed canola oil.

Stock-based Compensation

Following the Business Combination, the Company has authorized 555,000,000 shares including 500,000,000 Class A Ordinary Shares, 50,000,000 Class B Ordinary Shares, and 5,000,000 Preference Shares, each of par value $0.0001 per share. In addition, the Company has three classes of warrants ( i.e. , Public Warrants, Private Warrants and PIPE Warrants) issued and outstanding.

The assumptions used in calculating the fair value of stock-based compensation awards represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management’s judgment. As a result, if factors change and we use different assumptions, our stock-based compensation expense could be materially different in the future.

Warrant transactions

PIPE Warrants to purchase our Ordinary Shares are accounted for as liability or instruments based on the terms of the warrant agreements. The warrants issued by us are accounted for as liability instruments under IFRS 9 due to the rights of the grantee to require cash settlement.

Private Warrants and Representative Warrants to purchase units accounted for as liability instruments represent the warrants issued to significant shareholders and related parties.

Penny Warrants are a contingently issuable instrument to issue the Company’s shares and are accounted for as a financial liability.

Public Warrants are accounted for as equity instruments due to our ability to settle the warrants through the issuance of units.

In order to calculate warrant charges, we used the Monte Carlo simulations, which required key inputs including volatility and risk-free interest rate and certain unobservable inputs for which there is little or no market data, requiring us to develop our own assumptions. We estimated the fair value of unvested warrants, considered to be probable to be vesting, at the time. Based on that estimated fair value, we determined warrant charges, which were recorded as a reduction of the transaction price.

Off-Balance Sheet Arrangements

As of 31 March 2025 and 30 June 2024, we had no off-balance sheet arrangements as defined in Instruction 8 to Item 303(b) of Regulation S-K.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to market risk, including changes to interest rates and foreign currency exchange rates.

Interest Rate Sensitivity

We had cash and cash equivalents totaling AUD$1,435,123 and AUD$514,140 as of 31 March 2025, and 30 June 2024, respectively. Cash and cash equivalents include cash on hand and investments with original maturities of three months or less, are stated at cost, and approximate fair value. Our investment policy and strategy are focused on preservation of capital, supporting our liquidity requirements, and delivering competitive returns subject to prevailing market conditions. We were not exposed to material risks due to changes in market interest rates given the liquidity of the cash and investments with original maturity of three months.

Foreign Currency Risk

Although we are exposed to foreign currency risk from our international operations, we do not consider it to have a material impact. Certain transactions of the Company and its subsidiaries are denominated in currencies other than the functional currency.

Credit Risk

Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.

The Company’s cash and cash equivalents are generally held with large financial institutions. Although the Company’s deposits may exceed federally insured limits, the financial institutions that the Company uses have high investment-grade credit ratings and, as a result, the Company believes that, as of March 31, 2025, its risk relating to deposits exceeding federally insured limits was not significant.

The Company has no significant off-balance sheet risk such as foreign exchange contracts, options contracts, or other hedging arrangements.

The Company believes its credit policies are prudent and reflect normal industry terms and business risk. The Company generally does not require collateral from its customers and generally requires payment from zero to 90 days from the invoice date with typical terms of 30 days. As of 31 March, 2025, three customers accounted for 57.8% of the Company’s accounts receivable balance, and three customers accounted for more than 45.5% of the Company’s accounts receivable balance as of 31 March 2024.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act). Disclosure controls and procedures refer to controls and other procedures designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

As required by Rule 13a-15(e) of the Exchange Act, our management has carried out an evaluation, with the participation and under the supervision of our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as of March 31, 2025.

Based upon, and as of the date of this evaluation, our chief executive officer and chief financial officer determined that, because of the material weaknesses described in Item 9A “Controls and Procedures” of our Annual Report on Form 10-K/A for the fiscal year ended June 30, 2024, filed with the SEC on December 6, 2024, and further referenced below, which we are still in the process of remediating as of March 31, 2025, our disclosure controls and procedures were not effective.

The Company restated its consolidated balance sheet as of June 30, 2023 (the “2023 Restatement”). For a discussion of the individual restatement adjustments and the impact of such adjustments on the Company’s previously issued financial statements, see “Item 8., Note 2. Restatement of Previously Issued Financial Statements,” in our 10K lodged for 30 June 2024.

Changes in Internal Control Over Financial Reporting

This quarterly report does not include a report of management’s assessment regarding internal control over financial reporting or an attestation report of the company’s registered public accounting firm due to a transition period established by rules of the Securities and Exchange Commission for newly public companies.

PART II

OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

There were no material developments during the quarter ended March 31, 2025 to the legal proceedings previously disclosed in Item 3 “Legal Proceedings” of our Annual Report on Form 10-K/A filed on December 6, 2024.

ITEM 1A. RISK FACTORS.

For information regarding additional risk factors, please refer to our Annual Report on Form 10-K/A for the year ended June 30, 2024 filed with the SEC on December 6, 2024.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

We have not sold any equity securities during the quarter ended March 31, 2025 that were not previously disclosed in a current report on Form 8-K that was filed during the quarter.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

We have no information to disclose that was required to be in a report on Form 8-K during the quarter ended March 31, 2025 but was not reported. There have been no material changes to the procedures by which security holders may recommend nominees to our board of directors.

ITEM 6. EXHIBITS

Exhibit No.		Description
2.1		Business Combination Agreement, dated as of December 5, 2022, by and among EDOC Acquisition Corp., American Physicians LLC, Australian Oilseeds Holdings Limited, upon execution of a joinder agreement to become party thereto, AOI Merger Sub, upon execution of a joinder to become party thereto, Australian Oilseeds Investments Pty Ltd., Gary Seaton, in the capacity thereunder as the Seller Representative, and the shareholders of AOI named as Sellers therein (incorporated by reference to Exhibit 2.1 of EDOC’s Form 8-K filed with the SEC on December 9, 2022).
2.2		Amendment No. 1 to Business Combination Agreement, dated as of March 31, 2023, by and among EDOC Acquisition Corp., American Physicians LLC, Australian Oilseeds Holdings Limited and AOI Merger Sub (incorporated by reference to Exhibit 2.1 of EDOC’s Form 8-K filed with the SEC on April 6, 2023).
2.3		Amendment No. 2 to Business Combination Agreement, dated as of March 31, 2023, by and among EDOC Acquisition Corp., American Physicians LLC, Australian Oilseeds Holdings Limited and AOI Merger Sub (incorporated by reference to Exhibit 2.1 of EDOC’s Form 8-K filed with the SEC on December 7, 2023).
2.4		Agreement and Plan of Merger, dated as of March 21, 2024 between AOI Merger Sub Inc. and Edoc Acquisition Corp. (incorporated by reference to Annex C to the proxy statement/prospectus to Amendment No. 3 the Registration Statement on Form F-4 (File. No. 333-274552) of Australian Oilseeds Holdings Limited, filed with the SEC on January 30, 2024).
3.1		Amended and Restated Memorandum and Articles of Association of Australian Oilseeds Holdings Limited dated March 21, 2024 (incorporated by reference to Annex B to the proxy statement/prospectus to Amendment No. 3 the Registration Statement on Form F-4 (File. No. 333-274552) of Australian Oilseeds Holdings Limited, filed with the SEC on January 30, 2024).
31.1*		Certifications of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certifications of Principal Financial and Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*		Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*		Certification of Principal Financial and Accounting Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS		Inline XBRL Instance Document
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*	Filed herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: May 30, 2025	AUSTRALIAN OILSEEDS HOLDINGS LTD.

	/s/ Gary Seaton
	Name:	Gary Seaton
	Title:	Chief Executive Officer
		(Principal Executive Officer)

	/s/ Amarjeet Singh
	Name:	Amarjeet Singh
	Title:	Chief Financial Officer
		(Principal Financial and Accounting Officer)

TABLE OF CONTENTS

Note 31 March 2025 30 June 2024 Item 2. Management S Discussion and Analysis Of Financial Condition and Results Of Operations Item 7A. Quantitative and Qualitative Disclosures About Market Risk Item 3. Quantitative and Qualitative Disclosures About Market Risk Item 4. Controls and Procedures Part II Item 1. Legal Proceedings Item 1A. Risk Factors Item 2. Unregistered Sales Of Equity Securities and Use Of Proceeds Item 3. Defaults Upon Senior Securities Item 4. Mine Safety Disclosures Item 5. Other Information Item 6. Exhibits

Exhibits

2.1 Business Combination Agreement, dated as of December 5, 2022, by and among EDOC Acquisition Corp., American Physicians LLC, Australian Oilseeds Holdings Limited, upon execution of a joinder agreement to become party thereto, AOI Merger Sub, upon execution of a joinder to become party thereto, Australian Oilseeds Investments Pty Ltd., Gary Seaton, in the capacity thereunder as the Seller Representative, and the shareholders of AOI named as Sellers therein (incorporated by reference to Exhibit 2.1 of EDOCs Form 8-K filed with the SEC on December 9, 2022). 2.2 Amendment No. 1 to Business Combination Agreement, dated as of March 31, 2023, by and among EDOC Acquisition Corp., American Physicians LLC, Australian Oilseeds Holdings Limited and AOI Merger Sub (incorporated by reference to Exhibit 2.1 of EDOCs Form 8-K filed with the SEC on April 6, 2023). 2.3 Amendment No. 2 to Business Combination Agreement, dated as of March 31, 2023, by and among EDOC Acquisition Corp., American Physicians LLC, Australian Oilseeds Holdings Limited and AOI Merger Sub (incorporated by reference to Exhibit 2.1 of EDOCs Form 8-K filed with the SEC on December 7, 2023). 31.1* Certifications of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 31.2* Certifications of Principal Financial and Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 32.1* Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 32.2* Certification of Principal Financial and Accounting Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

COOT 10-Q Quarter ended March 31, 2025

Exhibits